syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	100.0
MYOCLONIC EPILEPSY OF LAFORA	1.5181307999999998	75.90653999999999
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	75.0
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.493772472	74.6886236
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.334248751	66.71243755
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.312397223	65.61986115
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	65.27777999999999
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1064611800000002	55.32305900000001
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0844468900000002	54.222344500000005
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.08404064	54.202032
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0833333	54.166665
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.05981838	52.990919000000005
ABLEPHARON-MACROSTOMIA SYNDROME	1.0434783	52.173915
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.043157972	52.157898599999996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.0415162930000001	52.075814650000005
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.0267238129999998	51.33619064999999
MOWAT-WILSON SYNDROME; MOWS	1.022695501	51.13477505
TRANSSEXUALITY	1.0188679	50.943395
MEVALONIC ACIDURIA; MEVA	1.016986512	50.84932559999999
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.0133333	50.666665
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.01259397	50.629698499999996
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	1.012123761	50.60618805
FRONTONASAL DYSPLASIA 1; FND1	1.01193639	50.5968195
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.0083350020000001	50.41675010000001
SPLENOPORTAL VASCULAR ANOMALIES	1.00440529	50.2202645
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.00440529	50.2202645
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.0028732230000001	50.14366115000001
HAMAMY SYNDROME; HMMS	1.00210084	50.105042
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	50.08798165
HYDROXYKYNURENINURIA	1.000843882	50.0421941
HEPATOCELLULAR CARCINOMA	1.0	50.0
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0	50.0
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	50.0
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	50.0
#615207 IL21R IMMUNODEFICIENCY	1.0	50.0
AGENESIS OF CEREBRAL WHITE MATTER	1.0	50.0
WILSON DISEASE	1.0	50.0
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	50.0
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	50.0
PHEOCHROMOCYTOMA	1.0	50.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	50.0
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	47.42063
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.8831414429999999	44.15707214999999
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.86008711	43.0043555
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.765549782	38.277489100000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	31.94443
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.624731933	31.23659665
HALOTHANE HEPATITIS	0.6147059	30.735295
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6065888	30.32944
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.6	30.0
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.6	30.0
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	30.0
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.5924711109999999	29.623555549999995
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.58444659	29.2223295
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.5842487510000001	29.212437550000004
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.583333	29.16665
THROMBOCYTOPENIA 1	0.583333	29.16665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.57566402	28.783201000000002
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.5555556	27.777780000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.5531420930000001	27.657104650000004
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5526316	27.63158
COMBINED SAPOSIN DEFICIENCY	0.54756461	27.3782305
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5436715900000001	27.183579500000004
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.543402351	27.17011755
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.5377719820000001	26.888599100000004
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	26.785715
TRICHOHEPATOENTERIC SYNDROME 1	0.53543414	26.771707
Congenital disorder of glycosylation, type IIh	0.532532282	26.6266141
AICARDI-GOUTIERES SYNDROME 5	0.529781502	26.489075099999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.528071752	26.4035876
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	25.735295
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.51008711	25.5043555
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.508090262	25.4045131
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.50680272	25.340136
IMMUNODEFICIENCY 36; IMD36	0.50440529	25.2202645
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.5028732229999999	25.143661149999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.5028732229999999	25.143661149999996
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.502029341	25.101467049999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.501957472	25.0978736
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.5017596329999999	25.087981649999996
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.50111359	25.0556795
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.501034123	25.05170615
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	25.04578755
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.500915751	25.04578755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.500674272	25.033713600000002
BRANCHIOOTORENAL SYNDROME 1	0.5	25.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	25.0
247150 LIP PRINTS	0.5	25.0
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	25.0
PHLEBECTASIA OF LIPS	0.5	25.0
IMMUNE DEFICIENCY DISEASE	0.5	25.0
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	25.0
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	25.0
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	23.318445
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	22.42063
CENTRALOPATHIC EPILEPSY	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	22.42063
SECKEL SYNDROME 2; SCKL2	0.43868059	21.934029499999998
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.416667	20.83335
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.396277972	19.813898599999998
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.3868371	19.341855
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.3866966810000001	19.334834050000005
PSEUDOXANTHOMA ELASTICUM; PXE	0.38361402	19.180701
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	19.123935
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	19.123935
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.381781472	19.0890736
EPILEPSY, JUVENILE ABSENCE	0.3752738	18.76369
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	18.76369
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.375238883	18.76194415
AICARDI SYNDROME; AIC	0.37156809	18.5784045
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.36781579999999997	18.39079
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.36662848	18.331424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.36256878200000003	18.1284391
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	18.06758
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	17.98244
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.357812972	17.8906486
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	17.4900941
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	17.401944999999998
PROPIONIC ACIDEMIA	0.34802083300000003	17.40104165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.3416193820000001	17.080969100000004
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.341495131	17.07475655
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.341495131	17.07475655
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.33901482	16.950741
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.338999523	16.94997615
CHROMOSOME 9P DELETION SYNDROME	0.337391312	16.8695656
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.33620622299999997	16.810311149999997
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.3361263	16.806314999999998
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.33543384	16.771691999999998
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.335362341	16.76811705
ALSTROM SYNDROME; ALMS	0.334569702	16.7284851
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.334248751	16.71243755
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.334248751	16.71243755
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.334248751	16.71243755
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.334176882	16.7088441
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.333452052	16.6726026
PSEUDO-VON WILLEBRAND DISEASE	0.333333	16.66665
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.333333	16.66665
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	16.66665
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.333333	16.66665
IMMUNODEFICIENCY 46; IMD46	0.333333	16.66665
DANDY-WALKER SYNDROME	0.333333	16.66665
PARAGANGLIOMAS 1	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	16.66665
PARAGANGLIOMAS 4	0.333333	16.66665
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.333333	16.66665
GRANGE SYNDROME; GRNG	0.333333	16.66665
PARAGANGLIOMAS 3	0.333333	16.66665
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	16.66665
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.32807778200000004	16.4038891
TUBEROUS SCLEROSIS	0.32591575100000003	16.29578755
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.31636785100000003	15.818392550000002
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.30550482300000004	15.275241150000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.297491772	14.8745886
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.29094398	14.547198999999999
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.29094398	14.547198999999999
GLUTAMINE DEFICIENCY, CONGENITAL	0.28976571100000004	14.488285550000002
#602398 DESMOSTEROLOSIS	0.287410573	14.37052865
MYASTHENIA GRAVIS; MG	0.2861266	14.30633
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.282036302	14.101815100000001
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.26739217200000004	13.369608600000001
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	13.235294999999999
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.26270877300000006	13.135438650000003
Pontine tegmental cap dysplasia	0.25925075300000006	12.962537650000003
INFANTILE LIVER FAILURE SYNDROME 2	0.258162131	12.908106550000001
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.25660082100000003	12.830041050000002
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.25568182	12.784091
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.254822641	12.741132050000001
CEPHALIN LIPIDOSIS	0.25408163	12.704081500000001
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.253709051	12.68545255
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.25210084	12.605042
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.25175963300000004	12.587981650000001
LOWE OCULOCEREBRORENAL SYNDROME	0.250915751	12.545787550000002
HYPERPARATHYROIDISM 2	0.25	12.5
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	12.5
TUFTSIN DEFICIENCY	0.25	12.5
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	12.5
DYSTONIA 6, TORSION	0.25	12.5
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25	12.5
PATENT DUCTUS VENOSUS	0.25	12.5
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	12.5
CEROID STORAGE DISEASE	0.25	12.5
118900 CIRRHOSIS, FAMILIAL	0.25	12.5
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.5
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.25	12.5
HYPEREKPLEXIA 1; HKPX1	0.25	12.5
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	12.5
LATHOSTEROLOSIS	0.22683723100000003	11.34186155
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	11.221404999999999
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	11.221404999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.22252534300000001	11.12626715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.212827072	10.6413536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.212827072	10.6413536
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.208137163	10.40685815
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.206044251	10.30221255
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.20497406299999998	10.248703149999999
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.20440529000000002	10.2202645
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.204058312	10.202915599999999
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.204058312	10.202915599999999
COHEN SYNDROME	0.202029341	10.10146705
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.202029341	10.10146705
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.20044194099999998	10.02209705
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	10.0
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.2	10.0
PHELAN-MCDERMID SYNDROME; PHMDS	0.19708602299999997	9.854301149999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	9.720704099999999
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.19440884000000003	9.720442000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.190895181	9.54475905
PEHO-LIKE SYNDROME; PEHOL	0.189963012	9.498150599999999
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.18988343300000005	9.494171650000002
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.1847667	9.238335000000001
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	9.1071691
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.064975
ADAMS-OLIVER SYNDROME 1; AOS1	0.179927173	8.99635865
CHROMOSOME 1P36 DELETION SYNDROME	0.17726845299999996	8.863422649999999
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17718612	8.859306
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.173945513	8.69727565
NIEMANN-PICK DISEASE, TYPE C2	0.173945513	8.69727565
PEHO SYNDROME; PEHO	0.17312445299999998	8.656222649999998
DUBOWITZ SYNDROME	0.17185464999999997	8.592732499999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.169540223	8.47701115
PYRUVATE CARBOXYLASE DEFICIENCY	0.169540223	8.47701115
GLUTARIC ACIDEMIA I; GA1	0.168696341	8.43481705
COFFIN-SIRIS SYNDROME 6; CSS6	0.168624472	8.4312236
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.166667	8.333350000000001
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.166667	8.333350000000001
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.166667	8.333350000000001
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.157244382	7.862219099999999
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.15496901200000002	7.748450600000001
GLYCEROL KINASE DEFICIENCY; GKD	0.15206506299999997	7.603253149999999
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.14852299	7.426149499999999
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14481447199999997	7.240723599999999
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1433483	7.167415000000001
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.141755841	7.08779205
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.14163939	7.0819695000000005
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.14064270199999998	7.032135099999999
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.140297712	7.0148855999999995
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.14006922000000002	7.0034610000000015
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.13764398	6.882199
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.785715000000001
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.135351923	6.767596150000001
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.7212250000000004
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.13328778100000002	6.664389050000001
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	6.49986905
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.29578755
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.287195
MUCOLIPIDOSIS IV; ML4	0.12100507200000002	6.050253600000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.12098920300000002	6.049460150000001
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.120743573	6.03717865
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.12051295100000001	6.02564755
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.119827822	5.9913911
TARP SYNDROME; TARPS	0.118983712	5.9491856
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.11702624000000002	5.851312000000001
COFFIN-SIRIS SYNDROME 2; CSS2	0.116206523	5.81032615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.11472626300000002	5.736313150000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.114416951	5.72084755
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.11402882	5.701441
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.11376480000000003	5.688240000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.11307080000000001	5.6535400000000005
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.11296033300000002	5.6480166500000015
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.11170170200000001	5.585085100000001
WITTEVEEN-KOLK SYNDROME	0.108471643	5.4235821500000005
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10818720000000001	5.40936
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	5.405435
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.10795800100000001	5.3979000500000005
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.107940741	5.397037050000001
WHITE-SUTTON SYNDROME; WHSUS	0.10764254200000001	5.3821271
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.10750485100000001	5.37524255
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.106904482	5.345224099999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.10652570200000001	5.326285100000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10568182000000001	5.284091
COACH SYNDROME	0.10555542300000002	5.277771150000001
JOUBERT SYNDROME 7	0.104750772	5.237538600000001
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.10440529000000001	5.220264500000001
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.10440529000000001	5.220264500000001
JOUBERT SYNDROME 2	0.10405831200000001	5.202915600000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10405831200000001	5.202915600000001
COFFIN-SIRIS SYNDROME 3; CSS3	0.10287322300000001	5.143661150000001
COFFIN-SIRIS SYNDROME 4; CSS4	0.10287322300000001	5.143661150000001
NAIL-PATELLA SYNDROME	0.1027933	5.139665
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.10274408299999999	5.13720415
MEIER-GORLIN SYNDROME 5; MGORS5	0.10210084000000001	5.105042000000001
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.10210084000000001	5.105042000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.10202934100000001	5.10146705
SCHOLTE SYNDROME; SHLTS	0.10111359	5.0556795
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.045787550000001
IMMUNODEFICIENCY 37; IMD37	0.10091575100000001	5.045787550000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.10091575100000001	5.045787550000001
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10091575100000001	5.045787550000001
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.10084388200000001	5.042194100000001
KRABBE DISEASE	0.100073931	5.00369655
DYSTONIA, JUVENILE-ONSET	0.1	5.0
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.0
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.1	5.0
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.1	5.0
HEPATITIS B VACCINE, RESPONSE TO	0.1	5.0
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.1	5.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.0
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	5.0
#119800 CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/ORMIRROR-IMAGE POLYDACTYLY; CCF	0.1	5.0
PATELLA APLASIA-HYPOPLASIA	0.1	5.0
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.0
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1	5.0
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.0
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.1	5.0
TRICHOHEPATOENTERIC SYNDROME 2	0.1	5.0
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.0
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.099001851	4.95009255
HEART AND BRAIN MALFORMATION SYNDROME	0.09866778300000001	4.93338915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.09785850099999999	4.89292505
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	4.885591
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09663488200000002	4.831744100000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.095360272	4.7680136
SITOSTEROLEMIA	0.09531439000000001	4.7657195
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.7495365000000005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.09268874100000002	4.634437050000001
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.09205983100000001	4.6029915500000005
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.5912425500000005
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.09155411300000002	4.577705650000001
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.09129130100000002	4.564565050000001
EVEN-PLUS SYNDROME	0.09121943200000002	4.560971600000001
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.5454550000000005
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.5454550000000005
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.5454550000000005
RCAD (renal cysts and diabetes)	0.0909091	4.5454550000000005
ATRANSFERRINEMIA	0.0909091	4.5454550000000005
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.09077800300000001	4.538900150000001
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.08979075300000001	4.489537650000001
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	4.44079
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.08845484	4.422742
RHEUMATOID ARTHRITIS	0.08791550000000001	4.395775
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.08691753	4.3458765
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.086614723	4.33073615
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.08620652300000001	4.310326150000001
ACROCALLOSAL SYNDROME; ACLS	0.08584778100000001	4.292389050000001
YUNIS-VARON SYNDROME	0.08560998	4.280499
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.08529077200000001	4.264538600000001
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.08514992100000002	4.257496050000001
CAROLI DISEASE, ISOLATED	0.08427718000000001	4.213859
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.08417718200000002	4.208859100000001
JOUBERT SYNDROME 23; JBTS23	0.08417718200000002	4.208859100000001
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.08417718200000002	4.208859100000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.08372582	4.186291000000001
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.08372582	4.186291000000001
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.08333330000000001	4.166665000000001
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.08333330000000001	4.166665000000001
LISSENCEPHALY, X-LINKED, 2	0.083034831	4.151741550000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08260492000000001	4.1302460000000005
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.08227069000000001	4.1135345
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.08190571999999999	4.095286
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.081553702	4.0776851
NIEMANN-PICK DISEASE, TYPE B	0.08132839000000001	4.0664195
TANGIER DISEASE; TGD	0.08132839000000001	4.0664195
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.079832	3.9916
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	3.9434449999999996
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.07837063	3.9185315
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	3.90625
LISSENCEPHALY 2; LIS2	0.07776698200000001	3.8883491000000006
WILLIAMS-BEUREN SYNDROME; WBS	0.07693313	3.8466565
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.07692310000000001	3.8461550000000004
MYOCLONUS AND ATAXIA	0.07692310000000001	3.8461550000000004
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.07692310000000001	3.8461550000000004
ATHEROSCLEROSIS SUSCEPTIBILITY	0.07692310000000001	3.8461550000000004
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.8461550000000004
HYPERLIPOPROTEINEMIA, TYPE V	0.07692310000000001	3.8461550000000004
FISH-EYE DISEASE	0.07692310000000001	3.8461550000000004
MCLEOD SYNDROME; MCLDS	0.07692310000000001	3.8461550000000004
CANAVAN DISEASE	0.07692310000000001	3.8461550000000004
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.07665828000000001	3.8329140000000006
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.07640266300000001	3.8201331500000006
LISSENCEPHALY 5; LIS5	0.075765941	3.78829705
MICROHYDRANENCEPHALY; MHAC	0.07529885	3.7649425
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.721175
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.721175
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.074373322	3.7186661
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.074278352	3.7139176000000003
Polyarteritis nodosa, childhood-onset	0.07353291	3.6766455000000002
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07352944000000002	3.676472000000001
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07352944000000002	3.676472000000001
STUVE-WIEDEMANN SYNDROME	0.07319263	3.6596314999999997
MYELOPEROXIDASE DEFICIENCY	0.07312923000000002	3.6564615000000007
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0728901	3.644505
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.07234435100000002	3.617217550000001
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07186239999999999	3.59312
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.07139782	3.569891
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	3.513075
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.513075
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.069952081	3.49760405
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.069351612	3.4675806000000002
COFFIN-SIRIS SYNDROME 1; CSS1	0.06902580300000001	3.4512901500000006
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.06889985	3.4449925
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.068845063	3.44225315
KABUKI SYNDROME 1	0.068166523	3.40832615
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.06801888	3.400944
MENTAL RETARDATION, X-LINKED 98; MRX98	0.06791592299999999	3.3957961499999993
FRANK-TER HAAR SYNDROME; FTHS	0.06757223000000001	3.3786115000000008
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.066916641	3.34583205
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.06690529	3.3452645000000003
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.06690529	3.3452645000000003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.06690529	3.3452645000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.066534233	3.32671165
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0660173	3.300865
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.065595913	3.2797956500000005
HARDIKAR SYNDROME	0.0654364	3.2718200000000004
#154780 MARSHALL SYNDROME; MRSHS	0.06543414	3.271707
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.06460084	3.2300420000000005
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.06424905100000002	3.212452550000001
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.06421729	3.2108645
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.06417718200000001	3.2088591000000006
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.20815
Growth hormone deficiency, isolated, type IA	0.0636363	3.1818150000000003
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.06333330000000001	3.1666650000000005
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	3.1621949999999996
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	3.1621949999999996
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.062917981	3.1458990499999997
RING CHROMOSOME 14 SYNDROME	0.062756602	3.1378300999999995
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0625	3.125
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0625	3.125
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.0625	3.125
IMMUNODEFICIENCY 62; IMD62	0.0625	3.125
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	3.125
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0625	3.125
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.062103871000000005	3.10519355
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.06164382	3.082191
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.060547433	3.02737165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.060148230999999996	3.0074115499999996
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.9944800000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.059824153000000005	2.99120765
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.059451933	2.97259665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.059139830000000004	2.9569915
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.058908402000000006	2.9454201
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.05882701	2.9413505
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.058608051	2.93040255
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.058245171	2.91225855
CYCLIC NEUTROPENIA	0.058184200000000005	2.9092100000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.057513072	2.8756535999999997
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.86647
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.056894721	2.8447360500000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.056823702000000004	2.8411851
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.832335
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.056457453000000005	2.8228726500000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.056457453000000005	2.8228726500000003
CHROMOSOME 18Q DELETION SYNDROME	0.056269260999999994	2.8134630499999997
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.055944	2.7972
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.055763072	2.7881536
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.7777800000000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.7777800000000004
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.7777800000000004
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.7777800000000004
CHROMOSOME 17q12 DELETION SYNDROME	0.055555600000000004	2.7777800000000004
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.7777800000000004
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.055504823	2.7752411500000003
EPILEPSY, PYRIDOXINE-DEPENDENT	0.055237902	2.7618951
OCULODENTODIGITAL DYSPLASIA; ODDD	0.055155670999999996	2.7577835499999996
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.054961912999999994	2.74809565
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.054864882000000004	2.7432441
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.054825490000000004	2.7412745000000003
YOU-HOOVER-FONG SYNDROME; YHFS	0.054589071999999995	2.7294536
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.7291100000000004
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.72529
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.72529
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.053906363	2.69531815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.053654282	2.6827141
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.053461281	2.67306405
OGDEN SYNDROME; OGDNS	0.052944722	2.6472360999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.05225316	2.612658
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.052232631	2.6116315500000002
KEIPERT SYNDROME; KPTS	0.05210084	2.605042
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05202429	2.6012145
SCLEROSING CHOLANGITIS, NEONATAL	0.05202429	2.6012145
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.051645972	2.5822986
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.05111359	2.5556795
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.050950142	2.5475071
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.050798363	2.53991815
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.05072468000000001	2.5362340000000003
KAGAMI-OGATA SYNDROME	0.050676632999999985	2.5338316499999993
MENTAL RETARDATION, BUENOS AIRES TYPE	0.05034864	2.517432
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	2.51488165
DIAMOND-BLACKFAN ANEMIA 8	0.05	2.5
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.05	2.5
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.05	2.5
NASODIGITOACOUSTIC SYNDROME	0.05	2.5
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.049922079999999994	2.496104
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.049378633	2.46893165
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.049201093	2.46005465
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.04908798	2.454399
GLYCOGEN STORAGE DISEASE IV	0.04873259	2.4366295
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.048731851	2.43659255
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.4269
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.4269
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.048376973	2.4188486499999997
KNIEST-LIKE DYSPLASIA, LETHAL	0.04815004	2.407502
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.048132872	2.4066436
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.048039200000000004	2.4019600000000003
RAGWEED SENSITIVITY	0.048039200000000004	2.4019600000000003
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.047619	2.38095
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.047619	2.38095
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.047619	2.38095
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.047619	2.38095
ADAMS-OLIVER SYNDROME 6; AOS6	0.047619	2.38095
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.047619	2.38095
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.04755534	2.377767
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.047411972	2.3705985999999997
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.047214133	2.36070665
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.047214133	2.36070665
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.047214133	2.36070665
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.046732281	2.33661405
HYPOADRENOCORTICISM, FAMILIAL	0.046623631000000006	2.33118155
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.046370251	2.31851255
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.046370251	2.31851255
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.046321882	2.3160941
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.046298382	2.3149191
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.046193152	2.3096576
JACOBSEN SYNDROME	0.04617235	2.3086175
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.0460492	2.30246
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.04602797199999999	2.3013985999999997
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.04587966	2.2939830000000003
RESTRICTIVE DERMOPATHY, LETHAL	0.04549895999999999	2.2749479999999997
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.0454545	2.272725
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.045435772000000006	2.2717886000000003
GABRIELE-DE VRIES SYNDROME; GADEVS	0.045427181999999997	2.2713590999999997
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.045287282	2.2643641
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.045107233	2.2553616499999998
POTOCKI-LUPSKI SYNDROME	0.044918953000000005	2.24594765
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.044720803	2.23604015
SHPRINTZEN OMPHALOCELE SYNDROME	0.04459189	2.2295945
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.04458787100000001	2.2293935500000006
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.044515472	2.2257736
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.044508900000000004	2.225445
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.044295721999999996	2.2147861
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.04412011299999999	2.2060056499999994
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.04412011299999999	2.2060056499999994
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.043856343000000006	2.19281715
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.04380909	2.1904545
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.043805363	2.19026815
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.043710672	2.1855336
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.173915
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.173915
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.173915
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.173915
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.173915
MAL DE MELEDA	0.043478300000000004	2.173915
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.173915
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.173915
BAZEX SYNDROME; BZX	0.043478300000000004	2.173915
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.173915
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.173915
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.173915
LIP, HAMARTOMATOUS	0.043478300000000004	2.173915
HOLOPROSENCEPHALY 7	0.043284683000000004	2.1642341500000004
FEINGOLD SYNDROME 1; FGLDS1	0.043272559999999995	2.1636279999999997
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.043149760999999995	2.1574880499999995
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.043041093	2.15205465
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.042979172	2.1489586000000003
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.042961481	2.14807405
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.042889612	2.1444806
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.042889612	2.1444806
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.042831503	2.14157515
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.042777652	2.1388826
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.042756550000000004	2.1378275
NAVAJO NEUROHEPATOPATHY	0.042537152	2.1268576
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	2.125851
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.04243094	2.121547
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.042102520000000004	2.1051260000000003
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.04204573	2.1022865
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.04200577	2.1002885
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.0932790999999997
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.041334723	2.0667361499999997
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0412548	2.0627400000000002
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.051085
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.040943980000000005	2.0471990000000004
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.040858282999999995	2.0429141499999997
ACRORENAL-MANDIBULAR SYNDROME	0.04056234	2.028117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.040555629999999995	2.0277814999999997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.040418972	2.0209485999999997
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.040418972	2.0209485999999997
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.040009301	2.00046505
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.039991041	1.99955205
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03979593000000001	1.9897965000000004
COUMARIN RESISTANCE	0.03979593000000001	1.9897965000000004
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9897965000000004
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.03979593000000001	1.9897965000000004
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9897965000000004
MACROCYTOSIS, FAMILIAL	0.03979593000000001	1.9897965000000004
FLOOD FACTOR DEFICIENCY	0.03979593000000001	1.9897965000000004
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03979593000000001	1.9897965000000004
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9897965000000004
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.03957509	1.9787545
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.03957509	1.9787545
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.03949891	1.9749455
COSTELLO SYNDROME; CSTLO	0.039479522	1.9739761000000002
COWDEN SYNDROME 6; CWS6	0.039377251	1.96886255
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.039377251	1.96886255
COWDEN SYNDROME 5; CWS5	0.039377251	1.96886255
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9652691
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.038949523	1.94747615
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.03884522199999999	1.9422610999999996
GOLDBERG-SHPRINTZEN SYNDROME	0.038718642	1.9359320999999998
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.03859	1.9295
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.038541112	1.9270556
MESOMELIA-SYNOSTOSES SYNDROME	0.0385076	1.92538
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0385076	1.92538
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.923075
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.923075
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.923075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.923075
BETHLEM MYOPATHY 1	0.0384615	1.923075
THUMB DEFORMITY	0.0384615	1.923075
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.923075
WATSON SYNDROME	0.0384615	1.923075
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.923075
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.923075
ARTERIES, ANOMALIES OF	0.0384615	1.923075
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.923075
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.923075
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.923075
MEIER-GORLIN SYNDROME 1; MGORS1	0.038424059999999996	1.9212029999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.038362302	1.9181151
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.038311481999999994	1.9155740999999997
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.038162291	1.90811455
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.038105641	1.90528205
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.03795062	1.8975309999999999
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.037886233	1.89431165
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.037815140000000004	1.8907570000000002
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.03769723	1.8848615
GITELMAN SYNDROME	0.037573931	1.87869655
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.037513341	1.87566705
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.037499391	1.87496955
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8707465000000003
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8707465000000003
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8707465000000003
ANGELMAN SYNDROME	0.037356023	1.86780115
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03724019	1.8620094999999999
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03724019	1.8620094999999999
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.03708468299999999	1.8542341499999997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.036998623	1.84993115
MYELOCEREBELLAR DISORDER	0.03693182	1.8465909999999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.8464049999999999
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.8464049999999999
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	1.8315025500000002
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.036512141	1.82560705
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.03649447199999999	1.8247235999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.036317801	1.81589005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.036242433000000004	1.8121216500000001
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03621452	1.810726
SMITH-MAGENIS SYNDROME; SMS	0.036206523	1.8103261499999999
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.036168702999999996	1.8084351499999998
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0361266	1.80633
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0361266	1.80633
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.035980423	1.79902115
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.035980423	1.79902115
VAN MALDERGEM SYNDROME 1; VMLDS1	0.03582863	1.7914315
VAN MALDERGEM SYNDROME 2; VMLDS2	0.03582863	1.7914315
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.03578221299999999	1.7891106499999996
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03577162	1.7885809999999998
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.03576092299999999	1.7880461499999996
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.035742	1.7871000000000001
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.035727502999999994	1.7863751499999996
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7857150000000002
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	1.7857150000000002
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7857150000000002
GASTRIC SNEEZING	0.035714300000000004	1.7857150000000002
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	1.7857150000000002
HEMOPOIETIC PROLIFERATION	0.035714300000000004	1.7857150000000002
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	1.7857150000000002
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	1.7857150000000002
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	1.7857150000000002
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7857150000000002
CHANARIN-DORFMAN SYNDROME	0.035714300000000004	1.7857150000000002
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.035714300000000004	1.7857150000000002
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	1.7857150000000002
EOSINOPHILOPENIA	0.035714300000000004	1.7857150000000002
METHANE PRODUCTION	0.035714300000000004	1.7857150000000002
ACETOPHENETIDIN SENSITIVITY	0.035714300000000004	1.7857150000000002
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7857150000000002
TERATOMA, PINEAL	0.035714300000000004	1.7857150000000002
BLUE DIAPER SYNDROME	0.035714300000000004	1.7857150000000002
MYELOMA, MULTIPLE	0.035714300000000004	1.7857150000000002
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	1.7857150000000002
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7857150000000002
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7857150000000002
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	1.7857150000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.03550885299999999	1.7754426499999996
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	1.7665815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.035279201999999996	1.7639600999999998
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.035191759999999996	1.7595879999999997
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.035186171999999995	1.7593085999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.035160903	1.75804515
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.03509362	1.754681
IMMUNODEFICIENCY 10; IMD10	0.03509362	1.754681
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.034988332999999996	1.74941665
MAJEED SYNDROME	0.03475939	1.7379695000000002
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.034549402	1.7274701
SCHIZOPHRENIA 1; SCZD1	0.0344828	1.72414
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.0344828	1.72414
CRANIOSYNOSTOSIS 4; CRS4	0.0344828	1.72414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.03443532	1.721766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03443532	1.721766
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.03442404	1.7212020000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.034395262999999995	1.7197631499999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.034165612	1.7082806
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.034123222999999994	1.7061611499999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.034123222999999994	1.7061611499999998
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.034123222999999994	1.7061611499999998
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.03395509199999999	1.6977545999999997
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.033940182	1.6970091
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.03393906	1.696953
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.03393480199999999	1.6967400999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.03381709	1.6908545000000001
FAMILIAL MEDITERRANEAN FEVER; FMF	0.03381709	1.6908545000000001
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.03379684000000001	1.6898420000000005
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.033584693	1.67923465
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.67869
ZUNICH NEUROECTODERMAL SYNDROME	0.033544440999999994	1.6772220499999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.033529003	1.67645015
GAUCHER DISEASE, PERINATAL LETHAL	0.033511901	1.6755950499999999
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.033425762	1.6712881
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.666665
SHORT SYNDROME	0.0333333	1.666665
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.666665
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.666665
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.666665
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.666665
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.666665
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.666665
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.666665
IMMUNE SUPPRESSION	0.0333333	1.666665
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.666665
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.666665
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.666665
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.033319243	1.66596215
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.033291713	1.66458565
METACHROMATIC LEUKODYSTROPHY	0.033279341	1.66396705
LETTERER-SIWE DISEASE	0.03320822	1.6604109999999999
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.033207471999999995	1.6603735999999998
PEROXISOME BIOGENESIS DISORDER 6B	0.033207471999999995	1.6603735999999998
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0331242	1.65621
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.033096299999999995	1.6548149999999997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.033091800000000005	1.6545900000000002
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.033090919999999996	1.6545459999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.033068102	1.6534051
LISSENCEPHALY 1; LIS1	0.033009633	1.65048165
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0328877	1.644385
HUNTER-MACDONALD SYNDROME	0.032585939999999994	1.6292969999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.032532282	1.6266141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.032532282	1.6266141
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.032428391	1.6214195500000002
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.032334501	1.61672505
MENKES DISEASE	0.032332340999999994	1.6166170499999997
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.032285022999999996	1.6142511499999999
MEGALENCEPHALY WITH DYSMYELINATION	0.032165751	1.60828755
Adrenoleukodystrophy	0.032165751	1.60828755
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032165751	1.60828755
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.032093882	1.6046941
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.032079333	1.60396665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.031694972	1.5847486000000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.03149882	1.574941
OSTEOPENIA AND SPARSE HAIR	0.031416589999999994	1.5708294999999997
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	1.5625
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03125	1.5625
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.5625
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	1.5625
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	1.5625
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.5609375499999998
15q13.3 microdeletion syndrome	0.031218750999999996	1.5609375499999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.03121399	1.5606995000000001
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	1.55857165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.031080740999999995	1.5540370499999998
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.030962041000000003	1.5481020500000002
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.030922712	1.5461356000000002
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.030704331	1.5352165500000001
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.030638381000000003	1.5319190500000002
INFANTILE SIALIC ACID STORAGE DISEASE	0.030480012999999997	1.5240006499999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.030402972000000004	1.5201486000000002
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.516545
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.516545
DIMPLES, FACIAL	0.030302999999999997	1.5151499999999998
DWARFISM, LEVI TYPE	0.030302999999999997	1.5151499999999998
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.5151499999999998
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.5151499999999998
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.5151499999999998
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.5151499999999998
OROFACIAL CLEFT 3	0.030302999999999997	1.5151499999999998
NASAL BONES, ABSENCE OF	0.030302999999999997	1.5151499999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.5151499999999998
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.5151499999999998
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.5151499999999998
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	1.5151499999999998
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.5151499999999998
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.5151499999999998
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.5151499999999998
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.5151499999999998
CLEFT CHIN	0.030302999999999997	1.5151499999999998
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.5151499999999998
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.5151499999999998
22q11.2 distal deletion syndrome	0.030302999999999997	1.5151499999999998
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.5151499999999998
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.030255682	1.5127841
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.030175682	1.5087841
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.030046290000000003	1.5023145000000002
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.029853371	1.49266855
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.029788580000000002	1.4894290000000001
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.029738511	1.48692555
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0297375	1.486875
TYSHCHENKO SYNDROME	0.029730452	1.4865226
ADENYLOSUCCINASE DEFICIENCY	0.029552453	1.47762265
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.4705899999999998
Yao syndrome	0.0294118	1.4705899999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.4705899999999998
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.4705899999999998
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
MARSILI SYNDROME; MARSIS	0.0294118	1.4705899999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	1.4705899999999998
DOHLE BODIES AND LEUKEMIA	0.0294118	1.4705899999999998
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.029112792	1.4556396
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.029100823	1.45504115
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.029047871	1.45239355
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.02899765	1.4498825
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.028922323	1.44611615
FRONTOOCULAR SYNDROME	0.028727941999999996	1.4363970999999998
POPOV-CHANG SYNDROME; POPCHAS	0.028621701999999995	1.4310850999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.028452072000000002	1.4226036000000002
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.42210755
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02829712	1.414856
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.028282799999999997	1.4141399999999997
HAREL-YOON SYNDROME; HAYOS	0.028273272000000002	1.4136636
MENTAL RETARDATION, X-LINKED 41	0.028273272000000002	1.4136636
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.028106191	1.40530955
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.028029370999999997	1.40146855
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.028029370999999997	1.40146855
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.027884059999999995	1.3942029999999999
FUMARASE DEFICIENCY; FMRD	0.027867622	1.3933811
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.027755781	1.38778905
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.027755781	1.38778905
KYPHOMELIC DYSPLASIA	0.027741840000000004	1.3870920000000002
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.027741840000000004	1.3870920000000002
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.027741840000000004	1.3870920000000002
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.027666233	1.38331165
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.027598472000000006	1.3799236000000004
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.027598472000000006	1.3799236000000004
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.027575920999999996	1.3787960499999998
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.027509352	1.3754676000000001
KOOLEN-DE VRIES SYNDROME; KDVS	0.027416273	1.37081365
GRACILE BONE DYSPLASIA; GCLEB	0.027400633000000004	1.3700316500000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.027338482	1.3669241
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.027294773	1.36473865
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.02721092	1.360546
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.02720361	1.3601805
%608572 BURN-MCKEOWN SYNDROME	0.027071549999999996	1.3535774999999999
CHROMOSOME 16Q22 DELETION SYNDROME	0.027048232000000002	1.3524116000000002
DIGEORGE SYNDROME; DGS	0.026850392999999997	1.3425196499999998
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.02684003	1.3420015
ROIFMAN SYNDROME; RFMN	0.026770962	1.3385481
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.026754590000000005	1.3377295000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.026754590000000005	1.3377295000000002
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.026622993	1.33114965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.026563323000000003	1.3281661500000002
DYSOSTEOSCLEROSIS	0.026556751000000003	1.3278375500000001
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026510442000000002	1.3255221000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0264946	1.32473
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.32473
THANATOPHORIC DYSPLASIA, TYPE I	0.026484882000000005	1.3242441000000003
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.026484882000000005	1.3242441000000003
SAUL-WILSON SYNDROME; SWILS	0.026484882000000005	1.3242441000000003
JOUBERT SYNDROME 10	0.026474111999999998	1.3237055999999998
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.026329021	1.31645105
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.31579
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.31579
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.31579
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02620435	1.3102175
CAMPOMELIC DYSPLASIA	0.02620435	1.3102175
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.026129023	1.30645115
Diamond-Blackfan anemia 1	0.02609002	1.304501
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.026006510999999996	1.3003255499999997
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.025934641999999997	1.2967320999999998
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.025927079999999998	1.296354
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.025879931000000002	1.2939965500000001
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.02578322	1.289161
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.025783219999999996	1.2891609999999998
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02571211	1.2856055
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.025688253	1.2844126500000002
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	0.025641000000000004	1.2820500000000001
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.025641000000000004	1.2820500000000001
MELNICK-NEEDLES SYNDROME	0.025641000000000004	1.2820500000000001
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.025641000000000004	1.2820500000000001
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.025641000000000004	1.2820500000000001
THANATOPHORIC DYSPLASIA, TYPE II	0.025641000000000004	1.2820500000000001
HYPOCHONDROPLASIA	0.025641000000000004	1.2820500000000001
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.025641000000000004	1.2820500000000001
#100800 ACHONDROPLASIA; ACH	0.025641000000000004	1.2820500000000001
#156550 KNIEST DYSPLASIA	0.025641000000000004	1.2820500000000001
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.025641000000000004	1.2820500000000001
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.025641000000000004	1.2820500000000001
OPTIC ATROPHY 11; OPA11	0.025213272000000002	1.2606636
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.025166922	1.2583461
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.025095423000000002	1.25477115
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.025090759999999997	1.254538
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.025089001	1.25445005
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.025072063	1.25360315
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.025056729999999996	1.2528364999999997
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.025050370000000002	1.2525185
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.025033412	1.2516706
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.025015433	1.25077165
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.025015433	1.25077165
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.024844371	1.24221855
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.024844371	1.24221855
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.024844371	1.24221855
XQ25 DUPLICATION SYNDROME	0.024639253	1.23196265
WEBB-DATTANI SYNDROME; WEDAS	0.024574663	1.22873315
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.024489829999999997	1.2244914999999998
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.02445878	1.222939
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.024454603000000002	1.22273015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024409602	1.2204800999999998
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.024336161	1.21680805
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.024268672999999998	1.2134336499999998
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.02419112	1.209556
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.02418953	1.2094765
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.20857755
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.20857755
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.024171551	1.20857755
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.20857755
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.024099682	1.2049841000000001
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.024099682	1.2049841000000001
HYPOPHOSPHATASIA, INFANTILE	0.023981620999999998	1.19908105
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.023919821999999997	1.1959910999999999
NOONAN SYNDROME 5; NS5	0.023919821999999997	1.1959910999999999
ADAMS-OLIVER SYNDROME 3; AOS3	0.023833801999999998	1.1916901
%300712 CRANIOFACIOSKELETAL SYNDROME	0.023833801999999998	1.1916901
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.023833801999999998	1.1916901
HADZISELIMOVIC SYNDROME	0.023769142	1.1884571
GAPO SYNDROME; GAPOS	0.023678271	1.18391355
RECOMBINANT CHROMOSOME 8 SYNDROME	0.023654953	1.18274765
HALLERMANN-STREIFF SYNDROME; HSS	0.02360946	1.1804729999999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.023511953000000002	1.17559765
ACROMICRIC DYSPLASIA	0.023434299999999998	1.1717149999999998
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.023434299999999998	1.1717149999999998
HURLER SYNDROME	0.023430971999999998	1.1715486
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02337871	1.1689355000000001
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.023360981	1.16804905
EPILEPSY, HOT WATER, 1	0.023335790000000002	1.1667895000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.023296011999999998	1.1648006
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.023281423	1.16407115
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02327319	1.1636595
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0232558	1.16279
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.16279
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0232558	1.16279
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.16279
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.16279
MEIER-GORLIN SYNDROME 8; MGORS8	0.023075939999999996	1.1537969999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.1533041000000002
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.1533041000000002
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.022989919999999997	1.1494959999999999
ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA	0.022989919999999997	1.1494959999999999
ZECHI-CEIDE SYNDROME	0.022989919999999997	1.1494959999999999
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.022989919999999997	1.1494959999999999
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1474765
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1474765
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1474765
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1474765
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	1.1434015499999999
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.022846412	1.1423206
WARBURG MICRO SYNDROME 2; WARBM2	0.02281503	1.1407515
HURLER-SCHEIE SYNDROME	0.022587089999999997	1.1293544999999998
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02258554	1.129277
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02253602	1.126801
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.022509039999999998	1.125452
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022424371	1.12121855
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.022365672	1.1182836
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.022365672	1.1182836
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.022352502	1.1176251
NOONAN SYNDROME 7; NS7	0.022311980999999998	1.11559905
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.022247391	1.11236955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.022240112	1.1120056
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.11111
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.11111
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.11111
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.11111
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.11111
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.022217252000000003	1.1108626000000001
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.02215433	1.1077165
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.022142752000000005	1.1071376000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.022104023	1.10520115
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.022104023	1.10520115
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.022082453000000002	1.10412265
MARDEN-WALKER SYNDROME	0.022030251	1.10151255
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	1.0976139999999999
GLYCINE ENCEPHALOPATHY; GCE	0.021892091000000002	1.0946045500000001
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.021816472	1.0908236
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.021802702000000004	1.0901351000000001
OROFACIODIGITAL SYNDROME XVI; OFD16	0.021777012	1.0888506
HYPERPROLINEMIA, TYPE I	0.021741123	1.08705615
FONTAINE PROGEROID SYNDROME; FPS	0.021724059999999996	1.0862029999999998
HYPERCALCEMIA, INFANTILE, 1	0.02169327	1.0846635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.021561053	1.07805265
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.0760895
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.02152179	1.0760895
TEMPLE SYNDROME	0.02152179	1.0760895
NEMALINE MYOPATHY 10	0.02152179	1.0760895
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02150862	1.075431
STIFF-PERSON SYNDROME; SPS	0.02150862	1.075431
CIRRHOSIS, FAMILIAL	0.02150862	1.075431
COFFIN-SIRIS SYNDROME 5	0.021470463000000002	1.0735231500000002
MUCOPOLYSACCHARIDOSIS, TYPE II	0.021447641	1.07238205
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.02137995	1.0689975
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	1.0661975499999998
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.021260141	1.06300705
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.021260141	1.06300705
PELGER-HUET ANOMALY; PHA	0.021231602	1.0615801
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.02118047	1.0590235
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.021166702	1.0583350999999999
Retinitis pigmentosa with or without skeletal anomalies	0.021126522	1.0563261
ALAZAMI SYNDROME; ALAZS	0.021126522	1.0563261
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021055023	1.05275115
PETTIGREW SYNDROME	0.021055023	1.05275115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.021055023	1.05275115
TEMPLE-BARAITSER SYNDROME; TMBTS	0.021055023	1.05275115
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.020989203	1.04946015
SIFRIM-HITZ-WEISS SYNDROME	0.02093313	1.0466565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.020825372	1.0412686
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.020825372	1.0412686
PRIMROSE SYNDROME; PRIMS	0.02082442	1.041221
CRI-DU-CHAT SYNDROME	0.020781729999999998	1.0390864999999998
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.020755181	1.03775905
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.020578763	1.02893815
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	1.0204099999999998
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	1.0204099999999998
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	1.0204099999999998
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	1.0204099999999998
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	1.0204099999999998
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	1.0204099999999998
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	1.0204099999999998
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	1.0204099999999998
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	1.0204099999999998
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	1.0204099999999998
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.020387719999999998	1.019386
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020387719999999998	1.019386
#256520 NEU-LAXOVA SYNDROME; NLS	0.02037555	1.0187775
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.020372422999999997	1.0186211499999998
GLYCOGEN STORAGE DISEASE II	0.02022478	1.011239
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.020184912	1.0092455999999999
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.020159840999999998	1.00799205
SECKEL SYNDROME 7; SCKL7	0.020146551	1.0073275499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.020146551	1.0073275499999998
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.020146551	1.0073275499999998
300270 ADRENOMYODYSTROPHY	0.020074682	1.0037341
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.020074682	1.0037341
CINCA SYNDROME; CINCA	0.02005349	1.0026745
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.02005349	1.0026745
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.02000091	1.0000455
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.019927723	0.9963861500000001
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.019927723	0.9963861500000001
ZIMMERMANN-LABAND SYNDROME 1	0.019767931	0.9883965499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	0.9855891
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.9855891
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.9855891
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	0.9855891
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.019615910000000004	0.9807955000000002
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.019526790000000002	0.9763395000000001
ASPARTYLGLUCOSAMINURIA; AGU	0.019444271	0.97221355
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01929539	0.9647695
CHITAYAT SYNDROME	0.01929539	0.9647695
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.019277953000000004	0.9638976500000002
ALLAN-HERNDON-DUDLEY SYNDROME	0.0192308	0.96154
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	0.96154
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0192308	0.96154
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01920923	0.9604615000000001
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01911119	0.9555595
IMMUNODEFICIENCY 32B; IMD32B	0.01911119	0.9555595
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.01911119	0.9555595
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01911119	0.9555595
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.01911119	0.9555595
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.01911119	0.9555595
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.01911119	0.9555595
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.01911119	0.9555595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.019107013000000003	0.9553506500000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.019097550999999997	0.9548775499999999
THAUVIN-ROBINET-FAIVRE SYNDROME	0.019025682	0.9512841
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.019025682	0.9512841
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01901837	0.9509185
JOUBERT SYNDROME 14	0.019001922	0.9500961
Helsmoortel-van der Aa syndrome	0.018999823	0.94999115
BARAITSER-WINTER SYNDROME 1; BRWS1	0.018891243000000002	0.9445621500000001
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.943395
THUMBS, CONGENITAL CLASPED	0.0188679	0.943395
JUMPING FRENCHMAN OF MAINE	0.0188679	0.943395
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.943395
CARDIAC ARRHYTHMIA	0.0188679	0.943395
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.943395
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	0.943395
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.943395
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.943395
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.943395
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.943395
MYOPATHY, CONGENITAL	0.0188679	0.943395
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.943395
ALCOHOL DEPENDENCE	0.0188679	0.943395
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.943395
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.943395
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.943395
MOTION SICKNESS	0.0188679	0.943395
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.943395
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.943395
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.943395
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.943395
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.943395
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.943395
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.943395
PALMOMENTAL REFLEX	0.0188679	0.943395
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.943395
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.943395
DIASTEMATOMYELIA	0.0188679	0.943395
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	0.943395
269800 SENILE PLAQUE FORMATION	0.0188679	0.943395
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.943395
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.943395
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.943395
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.943395
CERVICAL RIB	0.0188679	0.943395
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.943395
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.943395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	0.943395
ERYTHERMALGIA, PRIMARY	0.0188679	0.943395
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.943395
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.943395
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.943395
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.943395
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.943395
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.9393765000000001
SCHAAF-YANG SYNDROME; SHFYNG	0.018785872999999998	0.9392936499999999
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.018659293	0.9329646500000001
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.018654340999999998	0.9327170499999999
FRONTONASAL DYSPLASIA 2; FND2	0.01850963	0.9254815
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01844708	0.922354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.018434071000000003	0.9217035500000001
PITT-HOPKINS SYNDROME	0.018434071	0.92170355
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.018330681	0.9165340500000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.018290129999999998	0.9145064999999999
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01825684	0.912842
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 6; MGORS6	0.018181799999999998	0.90909
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.018181799999999998	0.90909
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.018181799999999998	0.90909
THREE M SYNDROME 2; 3M2	0.018181799999999998	0.90909
VELOCARDIOFACIAL SYNDROME	0.01816552	0.9082760000000001
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.018164363000000003	0.9082181500000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.018164363000000003	0.9082181500000002
COFFIN-SIRIS SYNDROME 8; CSS8	0.018155941	0.9077970499999999
FRYNS SYNDROME; FRNS	0.018123360999999998	0.9061680499999999
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.018084072	0.9042036
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.017987132000000003	0.8993566000000002
Myhre syndrome	0.017883831	0.89419155
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.017868363	0.8934181500000001
#170100 PROLIDASE DEFICIENCY	0.017805922000000002	0.8902961
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.017798623	0.88993115
IMMUNODEFICIENCY 49; IMD49	0.017798623	0.88993115
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.017656480000000002	0.882824
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.017545703	0.87728515
VICI SYNDROME; VICIS	0.017363903	0.86819515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.017327053000000002	0.8663526500000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.017327053000000002	0.8663526500000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017322412000000002	0.8661206000000001
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.017136111	0.8568055499999999
MARSHALL-SMITH SYNDROME; MRSHSS	0.0170594	0.8529699999999999
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.017026239999999998	0.8513119999999998
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01696808	0.848404
NOONAN SYNDROME 11; NS11	0.016952612000000002	0.8476306000000001
GAUCHER DISEASE, TYPE I	0.01688983	0.8444915000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.016882872	0.8441436
OROFACIODIGITAL SYNDROME I; OFD1	0.016861560999999997	0.8430780499999999
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.016735240999999998	0.8367620499999999
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.016663372	0.8331685999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.016629952	0.8314976
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.016558453	0.8279226500000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.016558453	0.8279226500000001
DESANTO-SHINAWI SYNDROME	0.016558453	0.8279226500000001
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	0.82703755
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	0.82703755
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.016483171	0.82415855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.016483171	0.82415855
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.8234441
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	0.8234441
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.8234441
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.8234441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.8234441
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	0.8234441
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.016278582	0.8139291
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.016278022	0.8139010999999999
ELSAHY-WATERS SYNDROME; ESWS	0.016278022	0.8139010999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.016213463	0.8106731500000001
3MC SYNDROME 3	0.01620541	0.8102705
3MC SYNDROME 1	0.01620541	0.8102705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.01614263	0.8071315000000001
NOONAN SYNDROME 4; NS4	0.016126599999999998	0.8063299999999999
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.01610873	0.8054365000000001
ARTERIAL TORTUOSITY SYNDROME	0.01598083	0.7990415000000001
CURRY-JONES SYNDROME	0.015950652000000003	0.7975326000000001
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.015944791	0.79723955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.015843663	0.7921831500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.015843663	0.7921831500000001
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.015839022	0.7919511
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.015801423000000002	0.79007115
METHYLMALONIC ACIDURIA, CBLA TYPE	0.015801423	0.7900711499999999
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.015693723000000003	0.7846861500000002
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.015693723000000003	0.7846861500000002
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.015693723000000003	0.7846861500000002
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.015693723000000003	0.7846861500000002
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.015693723	0.78468615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015693723	0.78468615
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.015642702	0.7821351000000001
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.78125
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.78125
PAINE SYNDROME	0.015625	0.78125
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.78125
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.78125
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.78125
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.78125
CARNOSINEMIA	0.015625	0.78125
HYDROXYLYSINURIA	0.015625	0.78125
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	0.78125
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.015621650999999999	0.7810825499999999
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.015621650999999999	0.7810825499999999
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7810825499999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7810825499999999
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.015600543	0.78002715
BOHRING-OPITZ SYNDROME	0.015600543	0.78002715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.015567419999999998	0.7783709999999999
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.7774891
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.7774891
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	0.7774891
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015444863	0.77224315
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.015434699999999999	0.771735
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.015434139999999999	0.7717069999999999
#611554 LEOPARD SYNDROME 2	0.015434139999999999	0.7717069999999999
MEIER-GORLIN SYNDROME 3; MGORS3	0.015434139999999999	0.7717069999999999
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.015434139999999999	0.7717069999999999
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.015434139999999999	0.7717069999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.015362641	0.76813205
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.015361013	0.76805065
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.015357801	0.76789005
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.015290772	0.7645386
HEMIFACIAL MICROSOMIA	0.01510677	0.7553385
FETAL AKINESIA SYNDROME, X-LINKED	0.01510677	0.7553385
MENTAL RETARDATION, X-LINKED 9	0.015092933	0.75464665
ADAMS-OLIVER SYNDROME 2; AOS2	0.015075063	0.75375315
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.015075063	0.75375315
Fabry disease	0.014964851	0.74824255
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.014964851	0.74824255
METHYLMALONIC ACIDURIA, CBLB TYPE	0.014885671999999999	0.7442835999999999
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.014885671999999999	0.7442835999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.014849841	0.7424920500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.014849841	0.7424920500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.014849841	0.7424920500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014849841	0.7424920500000001
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.014738461000000001	0.73692305
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.7352949999999999
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.7352949999999999
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0147059	0.7352949999999999
NEUROPATHY, PAINFUL	0.0147059	0.7352949999999999
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7352949999999999
DYSTONIA 12; DYT12	0.0147059	0.7352949999999999
PSORIASIS 14, PUSTULAR	0.0147059	0.7352949999999999
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.7352949999999999
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.7352949999999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.7352949999999999
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7352949999999999
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7352949999999999
CAFFEY DISEASE	0.0147059	0.7352949999999999
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7352949999999999
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7352949999999999
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7352949999999999
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.7352949999999999
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.7352949999999999
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.7352949999999999
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.7352949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.7352949999999999
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.7352949999999999
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0147059	0.7352949999999999
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.7352949999999999
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.7352949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.7352949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7352949999999999
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.7352949999999999
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.7352949999999999
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.7352949999999999
PANCREATITIS, HEREDITARY	0.0147059	0.7352949999999999
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.014687833	0.7343916500000001
CORNELIA DE LANGE SYNDROME 3	0.014653933000000001	0.7326966500000001
CYCLIC VOMITING SYNDROME	0.014623311	0.73116555
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.014580133000000002	0.7290066500000001
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014580133000000002	0.7290066500000001
HYPEREKPLEXIA 4; HKPX4	0.014580133000000002	0.7290066500000001
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.014580133000000002	0.7290066500000001
WARBURG MICRO SYNDROME 1	0.01453337	0.7266685
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.014524893	0.72624465
MENTAL RETARDATION, X-LINKED 19	0.014446889999999999	0.7223445
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.014419181	0.7209590499999999
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.014335531	0.7167765500000001
FOUNTAIN SYNDROME	0.014249050999999999	0.71245255
ATKIN-FLAITZ SYNDROME	0.014249050999999999	0.71245255
CLARK-BARAITSER SYNDROME	0.014249050999999999	0.71245255
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.014249050999999999	0.71245255
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.014249050999999999	0.71245255
TRISOMY 18-LIKE SYNDROME	0.014246990000000001	0.7123495000000001
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.014231180999999999	0.71155905
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.014182630000000002	0.7091315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.014177182	0.7088591
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.014177182	0.7088591
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.014159312	0.7079656
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.014159312	0.7079656
LAMB-SHAFFER SYNDROME	0.014159312	0.7079656
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014159312	0.7079656
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140491	0.702455
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0140491	0.702455
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.013965731	0.6982865500000001
GLASS SYNDROME	0.013961473	0.69807365
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.013947583	0.69737915
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.013934090000000001	0.6967045000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013934090000000001	0.6967045000000001
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.013934090000000001	0.6967045000000001
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.013905883	0.69529415
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.013742823	0.68714115
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.013742823	0.68714115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.013742823	0.68714115
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013742823	0.68714115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.013742823	0.68714115
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.013736251000000001	0.6868125500000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.013736251000000001	0.6868125500000001
CROME SYNDROME	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.013736251000000001	0.6868125500000001
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.013736251000000001	0.6868125500000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.013731043000000002	0.6865521500000001
PETERS-PLUS SYNDROME; PTRPLS	0.013696023	0.68480115
CHROMOSOME 13q14 DELETION SYNDROME	0.01368523	0.6842615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.013664382000000003	0.6832191000000001
NIEMANN-PICK DISEASE, TYPE A	0.013609142000000001	0.6804571
GALACTOSE EPIMERASE DEFICIENCY	0.013609142	0.6804570999999999
MECKEL SYNDROME, TYPE 1; MKS1	0.01354838	0.677419
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.013412110000000001	0.6706055000000001
PREECLAMPSIA/ECLAMPSIA 1	0.013400291	0.67001455
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.013400290999999998	0.6700145499999999
PROGNATHISM, MANDIBULAR	0.0133333	0.666665
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0133333	0.666665
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0133333	0.666665
MACS SYNDROME	0.0133333	0.666665
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01331543	0.6657715
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.01313025	0.6565124999999999
KAPUR-TORIELLO SYNDROME	0.013117591	0.65587955
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013038583	0.65192915
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.012986882	0.6493441
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.012974223	0.64871115
AICARDI-GOUTIERES SYNDROME 7	0.012960333000000001	0.6480166500000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.012960333000000001	0.6480166500000001
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.01295866	0.647933
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.01295866	0.647933
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.012912903	0.64564515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.012898940999999999	0.64494705
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.012898940999999999	0.64494705
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.012894300000000001	0.644715
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.012894300000000001	0.644715
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.012887161000000001	0.64435805
OHDO SYNDROME	0.012887161000000001	0.64435805
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.012820500000000002	0.6410250000000001
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 44	0.012820500000000002	0.6410250000000001
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.6410250000000001
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.6410250000000001
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.012820500000000002	0.6410250000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.012820500000000002	0.6410250000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.012815292000000002	0.6407646000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.012708773000000001	0.6354386500000001
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.012708773	0.63543865
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.012708773	0.63543865
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.012655821000000001	0.63279105
LISSENCEPHALY 3; LIS3	0.012655821	0.63279105
EMANUEL SYNDROME	0.012639923	0.6319961500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.012629233	0.63146165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012629233	0.63146165
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012629233	0.63146165
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.01259397	0.6296984999999999
CHYLOMICRON RETENTION DISEASE	0.01259397	0.6296984999999999
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.01259397	0.6296984999999999
MICROPHTHALMIA, SYNDROMIC 3	0.012583951999999999	0.6291975999999999
CRANIOFRONTONASAL SYNDROME; CFNS	0.012583951999999999	0.6291975999999999
WARBURG MICRO SYNDROME 3; WARBM3	0.012564500999999999	0.62822505
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01256113	0.6280565
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.012484539999999999	0.624227
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.012484539999999999	0.624227
ALPORT SYNDROME, X-LINKED; ATS	0.012484539999999999	0.624227
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.012484539999999999	0.624227
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.012484539999999999	0.624227
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.012484539999999999	0.624227
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.01238984	0.6194919999999999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.012386113	0.61930565
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.012386113	0.61930565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.012386113	0.61930565
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.012347393000000002	0.6173696500000001
SALLA DISEASE	0.012302443	0.61512215
MICROPHTHALMIA, SYNDROMIC 1	0.012271071000000001	0.6135535500000001
BARBER-SAY SYNDROME; BBRSAY	0.01220184	0.610092
OROFACIAL CLEFT 15	0.01220184	0.610092
OROFACIODIGITAL SYNDROME III	0.01220184	0.610092
15q26 overgrowth syndrome	0.01220184	0.610092
TRANSALDOLASE DEFICIENCY	0.01218795	0.6093974999999999
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01218795	0.6093974999999999
NEPHRONOPHTHISIS 1	0.012150310000000001	0.6075155000000001
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.012150310000000001	0.6075155000000001
ROWLEY-ROSENBERG SYNDROME	0.012150310000000001	0.6075155000000001
SENGERS SYNDROME	0.012143000000000001	0.6071500000000001
COCKAYNE SYNDROME A; CSA	0.012123761	0.60618805
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012058472	0.6029236
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.012039631	0.60198155
JABERI-ELAHI SYNDROME; JABELS	0.012016313	0.60081565
TEMTAMY SYNDROME; TEMTYS	0.012016313	0.60081565
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.012016312999999999	0.6008156499999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.012016312999999999	0.6008156499999999
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01198319	0.5991595
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.011945161	0.59725805
CHROMOSOME 3q13.31 DELETION SYNDROME	0.01193639	0.5968195
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011860633	0.59303165
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.011860633	0.59303165
GAUCHER DISEASE, TYPE II	0.011846743	0.59233715
CRANIOSYNOSTOSIS 6; CRS6	0.011793022	0.5896511
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.58926755
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.58926755
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.58926755
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.011773571	0.58867855
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.011713482	0.5856741000000001
3MC SYNDROME 2	0.011701702000000001	0.5850851
HYPERLIPOPROTEINEMIA, TYPE I	0.01165167	0.5825834999999999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.01165167	0.5825834999999999
HYPER-IGD SYNDROME	0.01165167	0.5825834999999999
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.011595183000000002	0.5797591500000001
OCULOCEREBROCUTANEOUS SYNDROME	0.011542231	0.57711155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.011542231	0.57711155
CORNELIA DE LANGE SYNDROME 1	0.011491711	0.57458555
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011470362000000001	0.5735181
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.011304692000000002	0.5652346
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.01127895	0.5639474999999999
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.01121459	0.5607295
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.011208010000000001	0.5604005000000001
THROMBOCYTHEMIA, ESSENTIAL	0.011208010000000001	0.5604005000000001
SICKLE CELL ANEMIA	0.011208010000000001	0.5604005000000001
TRIMETHYLAMINURIA	0.011208010000000001	0.5604005000000001
AMYLOIDOSIS, FAMILIAL VISCERAL	0.011208010000000001	0.5604005000000001
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.011172431	0.55862155
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.01115327	0.5576635
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.01112388	0.556194
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.01112388	0.556194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.01112388	0.556194
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.011100562	0.5550281
SECKEL SYNDROME 1; SCKL1	0.011081111	0.55405555
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.01102941	0.5514705
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.01102941	0.5514705
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.01102941	0.5514705
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.011025683	0.55128415
RENPENNING SYNDROME 1; RENS1	0.011016751	0.55083755
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.011016751	0.55083755
CHROMOSOME 5Q12 DELETION SYNDROME	0.011014113	0.55070565
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.011009242	0.5504621000000001
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.011002861	0.55014305
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.010961161	0.5480580500000001
DYSTONIA 28, CHILDHOOD-ONSET	0.010944882000000001	0.5472441
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.010930992	0.5465496000000001
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.010884350000000001	0.5442175
GLYCOGEN STORAGE DISEASE IXC	0.01086647	0.5433235
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.01085782	0.542891
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.01085782	0.542891
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.01085782	0.542891
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01085782	0.542891
BARAITSER-WINTER SYNDROME 2; BRWS2	0.010751301000000001	0.5375650500000001
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.010679432	0.5339716
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.010655883	0.53279415
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.01054281	0.5271405
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.010273102	0.5136550999999999
PSEUDOTRISOMY 13 SYNDROME	0.01025668	0.512834
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.010234753	0.5117376499999999
SIMOSA CRANIOFACIAL SYNDROME	0.01016536	0.508268
HYPERTELORISM AND TETRALOGY OF FALLOT	0.01016536	0.508268
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.010119603	0.50598015
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010119603	0.50598015
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010119603	0.50598015
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.010119603	0.50598015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.010119603	0.50598015
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010119603	0.50598015
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.010101	0.50505
RUIJS-AALFS SYNDROME; RJALS	0.010101	0.50505
260150 PALANT CLEFT PALATE SYNDROME	0.010101	0.50505
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.010101	0.50505
FACIAL ECTODERMAL DYSPLASIA	0.010101	0.50505
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010101	0.50505
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.010101	0.50505
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.010101	0.50505
NOSE, ANOMALOUS SHAPE OF	0.010101	0.50505
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.010098362000000001	0.5049181
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.010093860999999999	0.50469305
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01008711	0.5043555
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.01008711	0.5043555
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.01008711	0.5043555
IMMUNODEFICIENCY 52; IMD52	0.01008711	0.5043555
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.01008711	0.5043555
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.01008711	0.5043555
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.01008711	0.5043555
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.01008711	0.5043555
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01008711	0.5043555
SEA-BLUE HISTIOCYTE DISEASE	0.01008711	0.5043555
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01008711	0.5043555
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.010071813	0.50359065
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.010058840999999999	0.5029420499999999
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.01003968	0.501984
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.010018861	0.5009430500000001
HARTSFIELD SYNDROME; HRTFDS	0.009986972	0.49934860000000003
HOLOPROSENCEPHALY 2; HPE2	0.009915473000000001	0.49577365000000007
HOLOPROSENCEPHALY 1; HPE1	0.009915473000000001	0.49577365000000007
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.009915473	0.49577364999999995
CHROMOSOME 2q37 DELETION SYNDROME	0.009824153	0.49120765
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00975288	0.487644
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.009747442	0.48737210000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.009740131999999999	0.48700659999999996
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00942922	0.471461
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00942922	0.471461
CITRULLINE TRANSPORT DEFECT	0.00942922	0.471461
T-SUBSTANCE ANOMALY	0.00942922	0.471461
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00942922	0.471461
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.009405902	0.4702951
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.009405901999999999	0.47029509999999997
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.009379353	0.46896765
MAPLE SYRUP URINE DISEASE; MSUD	0.009275720999999999	0.46378604999999995
EPISODIC ATAXIA, TYPE 6	0.009275720999999999	0.46378604999999995
CODAS SYNDROME	0.009250753	0.46253765
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.009250753	0.46253765
STROMME SYNDROME; STROMS	0.00914309	0.45715449999999996
HYDROLETHALUS SYNDROME 1	0.00914309	0.45715449999999996
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00914309	0.45715449999999996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00914309	0.45715449999999996
FOCAL DERMAL HYPOPLASIA; FDH	0.00914309	0.45715449999999996
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00914309	0.45715449999999996
MECKEL SYNDROME 12; MKS12	0.00914309	0.45715449999999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.009071591	0.45357955
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009071591	0.45357955
CHROMOSOME 10Q26 DELETION SYNDROME	0.009055693	0.45278465
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009006013	0.45030065
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.009006013	0.45030065
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.009006013	0.45030065
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.009006013	0.45030065
ARGININOSUCCINIC ACIDURIA	0.009006013	0.45030065
CITRULLINEMIA, CLASSIC	0.009006013	0.45030065
GENITOPATELLAR SYNDROME; GTPTS	0.008999722	0.4499861
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008999722	0.4499861
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.008999722	0.4499861
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.008980271	0.44901355
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.008908402000000001	0.44542010000000004
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.008908402000000001	0.44542010000000004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.008908402000000001	0.44542010000000004
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00890356	0.44517799999999996
BAND HETEROTOPIA; BH	0.008801883	0.44009415
LISSENCEPHALY 4	0.008801883	0.44009415
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.008801883	0.44009415
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.008801883	0.44009415
GABA-TRANSAMINASE DEFICIENCY	0.008801883	0.44009415
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.008801883	0.44009415
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.008760192	0.4380096
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.008626542000000001	0.4313271000000001
FORSYTHE-WAKELING SYNDROME; FWS	0.008626542	0.43132709999999996
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.008626542	0.43132709999999996
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.008626542	0.43132709999999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.008558293	0.42791465
AL KAISSI SYNDROME; ALKAS	0.008558293	0.42791465
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008558293	0.42791465
ZTTK SYNDROME; ZTTKS	0.008558293	0.42791465
FOLATE MALABSORPTION, HEREDITARY	0.008555043	0.42775215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.008555043	0.42775215
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.008555043	0.42775215
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00848692	0.424346
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00848692	0.424346
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00848692	0.424346
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.008478369999999999	0.4239185
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00847512	0.42375599999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00835997	0.4179985
PORPHYRIA, ACUTE HEPATIC	0.00835997	0.4179985
ACID PHOSPHATASE DEFICIENCY	0.00835997	0.4179985
LIVER FAILURE, INFANTILE, TRANSIENT	0.00835997	0.4179985
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00835997	0.4179985
LESCH-NYHAN SYNDROME; LNS	0.00835997	0.4179985
JOUBERT SYNDROME 21	0.008335002000000001	0.41675010000000007
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.008292312000000001	0.4146156000000001
KLEEFSTRA SYNDROME 2; KLEFS2	0.008220813	0.41104065
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.008220813	0.41104065
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.008220813	0.41104065
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.008220813	0.41104065
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.008220813	0.41104065
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.008220813	0.41104065
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.008220813	0.41104065
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.008211811	0.41059055
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.008162131	0.40810654999999996
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.008162131	0.40810654999999996
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.008162131	0.40810654999999996
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.008162131	0.40810654999999996
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.40810654999999996
PAPILLOMA OF CHOROID PLEXUS	0.008162131	0.40810654999999996
CHIARI MALFORMATION TYPE II	0.00815584	0.407792
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00815584	0.407792
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.008140890000000001	0.4070445000000001
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.008140890000000001	0.4070445000000001
LARSEN-LIKE SYNDROME	0.008139942	0.40699710000000006
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00806452	0.40322600000000003
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00806452	0.40322600000000003
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00806452	0.40322600000000003
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00806452	0.40322600000000003
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00806452	0.40322600000000003
MENTAL RETARDATION, X-LINKED 92	0.00806452	0.40322600000000003
OMODYSPLASIA 1; OMOD1	0.00806452	0.40322600000000003
PFEIFFER-PALM-TELLER SYNDROME	0.00806452	0.40322600000000003
SECKEL SYNDROME 5; SCKL5	0.00806452	0.40322600000000003
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00806452	0.40322600000000003
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00806452	0.40322600000000003
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00806452	0.40322600000000003
RAPADILINO SYNDROME	0.00806452	0.40322600000000003
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00806452	0.40322600000000003
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00806452	0.40322600000000003
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00806452	0.40322600000000003
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007958001	0.39790004999999995
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.007958001	0.39790004999999995
LISSENCEPHALY, X-LINKED, 1; LISX1	0.007958001	0.39790004999999995
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.3943066
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.007886132	0.3943066
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.007886132	0.3943066
HOLOPROSENCEPHALY 11	0.007886132	0.3943066
SEPTOOPTIC DYSPLASIA	0.007886132	0.3943066
CRANIOTELENCEPHALIC DYSPLASIA	0.007886132	0.3943066
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.007886132	0.3943066
WIEACKER-WOLFF SYNDROME	0.007767363000000001	0.3883681500000001
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.007767363000000001	0.3883681500000001
SHASHI-PENA SYNDROME; SHAPNS	0.007767363000000001	0.3883681500000001
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.38592355
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.007718471	0.38592355
KEUTEL SYNDROME; KTLS	0.007718471	0.38592355
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.007718471	0.38592355
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.38592355
SNEDDON SYNDROME	0.007718471	0.38592355
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.38592355
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.007714411	0.38572055
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.007714411	0.38572055
PSEUDO-TORCH SYNDROME 2	0.007711160999999999	0.38555805
SMITH-KINGSMORE SYNDROME; SKS	0.007711160999999999	0.38555805
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.007646602	0.3823301
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007646602	0.3823301
BARDET-BIEDL SYNDROME 1; BBS1	0.007646602	0.3823301
XIA-GIBBS SYNDROME	0.0076425419999999996	0.3821271
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0076425419999999996	0.3821271
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.007448430000000001	0.3724215
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.007448430000000001	0.3724215
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.007448430000000001	0.3724215
611961 STEVENSON-CAREY SYNDROME	0.007444703	0.37223515
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.007444703	0.37223515
MIRAGE SYNDROME; MIRAGE	0.007441453	0.37207265
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.007441453	0.37207265
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.007376931000000001	0.36884655000000005
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.007376931000000001	0.36884655000000005
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.007350012	0.3675006
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.007305062	0.3652531
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.007305062	0.3652531
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007305062	0.3652531
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.007305062	0.3652531
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.007305062	0.3652531
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.007293281	0.36466405
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.007278513	0.36392565
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.362319
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.362319
VISCERAL MYOPATHY; VSCM	0.00724638	0.362319
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00724638	0.362319
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.362319
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.362319
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00724638	0.362319
VALINEMIA	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.362319
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.362319
GALACTOSEMIA	0.00724638	0.362319
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00724638	0.362319
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.362319
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.362319
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.362319
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.362319
EPISODIC ATAXIA, TYPE 3	0.00724638	0.362319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.362319
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.362319
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.362319
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.362319
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.362319
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.362319
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.362319
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.362319
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00724638	0.362319
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.362319
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.362319
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.362319
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00724638	0.362319
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.362319
PORPHYRIA VARIEGATA	0.00724638	0.362319
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.362319
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.362319
PROTEUS SYNDROME	0.00719859	0.3599295
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00719859	0.3599295
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.007107223	0.35536115
OCULOECTODERMAL SYNDROME; OES	0.007107223	0.35536115
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.007107223	0.35536115
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.007107223	0.35536115
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.007107223	0.35536115
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007107223	0.35536115
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.3521125
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.3521125
SCHIZENCEPHALY	0.00704225	0.3521125
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00704225	0.3521125
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME XV; OFD15	0.00704225	0.3521125
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME V; OFD5	0.00704225	0.3521125
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00704225	0.3521125
MASA SYNDROME	0.00704225	0.3521125
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00704225	0.3521125
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.3521125
AGNATHIA-OTOCEPHALY COMPLEX	0.00704225	0.3521125
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00704225	0.3521125
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00704225	0.3521125
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00704225	0.3521125
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00704225	0.3521125
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006954853	0.34774265000000004
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.006954853	0.34774265000000004
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.006954853	0.34774265000000004
SPINOCEREBELLAR ATAXIA 47; SCA47	0.006923481000000001	0.34617405000000007
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.006923481000000001	0.34617405000000007
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.0068749300000000005	0.3437465
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.0068749300000000005	0.3437465
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0068749300000000005	0.3437465
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.0068749300000000005	0.3437465
JOUBERT SYNDROME 1	0.006851612000000001	0.34258060000000007
COHEN-GIBSON SYNDROME; COGIS	0.006851612000000001	0.34258060000000007
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006851612000000001	0.34258060000000007
JOUBERT SYNDROME 35; JBTS35	0.006851612000000001	0.34258060000000007
LONG QT SYNDROME 13; LQT13	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.340136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.340136
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.340136
ALAGILLE SYNDROME 2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.340136
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00680272	0.340136
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.340136
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00680272	0.340136
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.340136
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.340136
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.340136
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.340136
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.340136
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.340136
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.340136
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.340136
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.340136
Paragangliomas 6	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.340136
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00680272	0.340136
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.340136
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.340136
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.340136
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.340136
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.340136
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.340136
SECKEL SYNDROME 10; SCKL10	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.340136
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.340136
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.340136
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.340136
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.340136
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.340136
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.340136
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.340136
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.340136
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.340136
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00680272	0.340136
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.340136
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.340136
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00680272	0.340136
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.340136
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.340136
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.340136
POLYCYSTIC KIDNEYS	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.340136
XFE PROGEROID SYNDROME; XFEPS	0.00680272	0.340136
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.00680272	0.340136
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.340136
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00679866	0.339933
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.006653773	0.33268865
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.006653773	0.33268865
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006653773	0.33268865
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006600821000000001	0.33004105000000006
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.006600821000000001	0.33004105000000006
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.006600821	0.33004105
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.006597571	0.32987855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.32987855
THYROCEREBRORETINAL SYNDROME	0.006597571	0.32987855
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.006597571	0.32987855
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006528952	0.3264476
TURNPENNY-FRY SYNDROME; TPFS	0.006528952	0.3264476
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0065257019999999995	0.3262851
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0065257019999999995	0.3262851
LIG4 SYNDROME	0.0065257019999999995	0.3262851
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0065257019999999995	0.3262851
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.006506130000000001	0.32530650000000005
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.006506130000000001	0.32530650000000005
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00646118	0.32305900000000004
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00646118	0.32305900000000004
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00646118	0.32305900000000004
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.006457453	0.32287265
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.006457453	0.32287265
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.006457453	0.32287265
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.006457453	0.32287265
MEHMO SYNDROME; MEHMO	0.006457453	0.32287265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006457453	0.32287265
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.006457453	0.32287265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.006457453	0.32287265
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.006457453	0.32287265
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.006457453	0.32287265
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.006457453	0.32287265
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.006457453	0.32287265
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.006457453	0.32287265
NEURAMINIDASE DEFICIENCY	0.0064346310000000006	0.32173155000000003
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.006362762	0.3181381
THREONINEMIA	0.006263341	0.31316705
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.006191472	0.3095736
NEPHRONOPHTHISIS 11; NPHP11	0.006191472	0.3095736
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.006191472	0.3095736
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.006191472	0.3095736
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.006191472	0.3095736
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.006182470000000001	0.30912350000000005
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.006164923	0.30824615
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.006110971	0.30554855
XYLOSIDASE DEFICIENCY	0.006110971	0.30554855
JOUBERT SYNDROME 3; JBTS3	0.006007730000000001	0.30038650000000006
LATERAL MENINGOCELE SYNDROME	0.006007730000000001	0.30038650000000006
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.006007730000000001	0.30038650000000006
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.006007730000000001	0.30038650000000006
VERVERI-BRADY SYNDROME; VERBRAS	0.006007730000000001	0.30038650000000006
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00600773	0.3003865
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00600773	0.3003865
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.29206315
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.005841263	0.29206315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005809891000000001	0.2904945500000001
BRANCHIOOCULOFACIAL SYNDROME	0.005809891	0.29049455
AYME-GRIPP SYNDROME; AYGRP	0.005809891	0.29049455
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.005738022000000001	0.2869011
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.005738022000000001	0.2869011
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.005738022000000001	0.2869011
CREE MENTAL RETARDATION SYNDROME	0.005738022	0.28690109999999996
CHAR SYNDROME	0.005738022	0.28690109999999996
CEREBROOCULONASAL SYNDROME	0.00568507	0.28425350000000005
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00568507	0.28425350000000005
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.284091
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.284091
Bernard-Soulier syndrome	0.00568182	0.284091
DK PHOCOMELIA SYNDROME	0.00568182	0.284091
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.284091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00568182	0.284091
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.00568182	0.284091
WT LIMB-BLOOD SYNDROME	0.00568182	0.284091
SEBASTIAN SYNDROME	0.00568182	0.284091
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.00568182	0.284091
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.284091
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.284091
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.284091
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.284091
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.284091
FANCONI ANEMIA	0.00568182	0.284091
STORMORKEN SYNDROME; STRMK	0.00568182	0.284091
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00568182	0.284091
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.284091
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.284091
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00568182	0.284091
EOSINOPHILIA, FAMILIAL	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00568182	0.284091
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.284091
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.284091
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00568182	0.284091
FECHTNER SYNDROME	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.284091
THROMBOCYTOPENIA 3	0.00568182	0.284091
NIJMEGEN BREAKAGE SYNDROME	0.00568182	0.284091
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.284091
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.284091
MONOSOMY 7 OF BONE MARROW	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.284091
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.284091
IVIC SYNDROME	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00568182	0.284091
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00568182	0.284091
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.284091
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.284091
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00568182	0.284091
PLATELET DISORDER, UNDEFINED	0.00568182	0.284091
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.284091
THROMBOCYTOPENIA 5; THC5	0.00568182	0.284091
THROMBOCYTOPENIA 6	0.00568182	0.284091
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.284091
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00568182	0.284091
THROMBOCYTOPENIA 2	0.00568182	0.284091
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005666523000000001	0.28332615000000005
LEIGH SYNDROME; LS	0.005666523000000001	0.28332615000000005
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.005666523000000001	0.28332615000000005
JOUBERT SYNDROME 30; JBTS30	0.005666523000000001	0.28332615000000005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005666523000000001	0.28332615000000005
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.005666523000000001	0.28332615000000005
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005666523000000001	0.28332615000000005
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005666523000000001	0.28332615000000005
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.005613571	0.28067855
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.005613571	0.28067855
MENTAL RETARDATION, X-LINKED 102	0.005613571	0.28067855
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.005613571	0.28067855
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.005541702	0.2770851
JOUBERT SYNDROME 31; JBTS31	0.005541702	0.2770851
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005541702	0.2770851
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.005541702	0.2770851
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.005541702	0.2770851
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00551888	0.275944
BARTH SYNDROME; BTHS	0.00534759	0.2673795
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00534759	0.2673795
TYROSINE TRANSAMINASE DEFICIENCY	0.00534759	0.2673795
#613291 BILE ACID MALABSORPTION, PRIMARY; PBAM	0.00534759	0.2673795
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00534759	0.2673795
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00534759	0.2673795
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00534759	0.2673795
FORMIMINOTRANSFERASE DEFICIENCY	0.00534759	0.2673795
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.00534759	0.2673795
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00534759	0.2673795
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00534759	0.2673795
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.00534759	0.2673795
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	0.00534759	0.2673795
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00534759	0.2673795
#610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;;CMO II DEFICIENCY;;ALDOSTERONE DEFICIENCY II;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;;ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;;STEROID 18-OXIDASE DEFICIENCY;;18-@OXIDASE DEFICIENCY	0.00534759	0.2673795
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00534759	0.2673795
LYSINE MALABSORPTION SYNDROME	0.00534759	0.2673795
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00534759	0.2673795
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00534759	0.2673795
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00534759	0.2673795
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00534759	0.2673795
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00534759	0.2673795
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00534759	0.2673795
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00534759	0.2673795
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.00534759	0.2673795
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00534759	0.2673795
GLYCOGEN STORAGE DISEASE IXA	0.00534759	0.2673795
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00534759	0.2673795
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00534759	0.2673795
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00534759	0.2673795
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00534759	0.2673795
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00534759	0.2673795
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00534759	0.2673795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00534759	0.2673795
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00534759	0.2673795
#266600 INFLAMMATORY BOWEL DISEASE 1; IBD1REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED	0.00534759	0.2673795
DIAMOND-BLACKFAN ANEMIA 9	0.00534759	0.2673795
NEPHRONOPHTHISIS 4	0.00534759	0.2673795
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00534759	0.2673795
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00534759	0.2673795
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00534759	0.2673795
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00534759	0.2673795
COLOBOMA, OCULAR	0.00534759	0.2673795
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00534759	0.2673795
#615468 IMMUNODEFICIENCY 12; IMD12	0.00534759	0.2673795
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00534759	0.2673795
NATHALIE SYNDROME	0.00534759	0.2673795
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00534759	0.2673795
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00534759	0.2673795
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.26719315
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.005343863	0.26719315
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005343863	0.26719315
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.005343863	0.26719315
LISSENCEPHALY 8; LIS8	0.005343863	0.26719315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005343863	0.26719315
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005343863	0.26719315
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.005343863	0.26719315
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.26719315
Xq28 (MECP2) duplication	0.005343863	0.26719315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.26719315
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.005343863	0.26719315
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005343863	0.26719315
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005321041	0.26605205000000004
GAUCHER DISEASE, TYPE IIIC	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005321041	0.26605205000000004
ADAMS-OLIVER SYNDROME 5; AOS5	0.005321041	0.26605205000000004
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.005321041	0.26605205000000004
IMMUNODEFICIENCY 47	0.005321041	0.26605205000000004
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.005249172	0.2624586
MACROCEPHALY/AUTISM SYNDROME	0.005249172	0.2624586
LYMPHEDEMA, HEREDITARY, III	0.005249172	0.2624586
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.005249172	0.2624586
OCULOSKELETODENTAL SYNDROME; OCSKD	0.005249172	0.2624586
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00519522	0.259761
ETHANOLAMINOSIS	0.00519522	0.259761
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00519522	0.259761
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00519522	0.259761
EHLERS-DANLOS SYNDROME, TYPE VI	0.00519522	0.259761
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.24986905
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.24986905
EPILEPSY-TELANGIECTASIA	0.004997381	0.24986905
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.24986905
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004974063	0.24870314999999998
#300867 KABUKI SYNDROME 2; KABUK2	0.004974063	0.24870314999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.004974063	0.24870314999999998
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004974063	0.24870314999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.004974063	0.24870314999999998
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.004974063	0.24870314999999998
C SYNDROME	0.004974063	0.24870314999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004974063	0.24870314999999998
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004974063	0.24870314999999998
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.004974063	0.24870314999999998
CHROMOSOME 16p13.2 DELETION SYNDROME	0.004974063	0.24870314999999998
MEND SYNDROME; MEND	0.004974063	0.24870314999999998
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.004974063	0.24870314999999998
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004974063	0.24870314999999998
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004974063	0.24870314999999998
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004974063	0.24870314999999998
REVESZ SYNDROME	0.004925512	0.24627559999999998
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00489414	0.244707
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00489414	0.244707
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00489414	0.244707
NOONAN SYNDROME 8; NS8	0.00489414	0.244707
TEEBI-SHALTOUT SYNDROME; TBSH	0.00489414	0.244707
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00489414	0.244707
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00489414	0.244707
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00489414	0.244707
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00489414	0.244707
WIDOW&#39;S PEAK SYNDROME	0.00489414	0.244707
SCARF SYNDROME	0.00489414	0.244707
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00489414	0.244707
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.004822641000000001	0.24113205000000004
PALLISTER-KILLIAN SYNDROME	0.004822641000000001	0.24113205000000004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004750772	0.23753860000000002
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004750772	0.23753860000000002
AU-KLINE SYNDROME; AUKS	0.004750772	0.23753860000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004750772	0.23753860000000002
HYPOTONIA-CYSTINURIA SYNDROME	0.004750772	0.23753860000000002
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.004750772	0.23753860000000002
ARIMA SYNDROME	0.004750772	0.23753860000000002
JOUBERT SYNDROME 26	0.004750772	0.23753860000000002
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00469782	0.23489100000000002
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00469782	0.23489100000000002
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00469782	0.23489100000000002
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.004552933	0.22764665
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.004552933	0.22764665
Muenke syndrome	0.004552933	0.22764665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004552933	0.22764665
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004499981	0.22499905
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.004499981	0.22499905
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004499981	0.22499905
RETT SYNDROME, CONGENITAL VARIANT	0.004499981	0.22499905
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004499981	0.22499905
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004499981	0.22499905
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004499981	0.22499905
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004499981	0.22499905
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004499981	0.22499905
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.22499905
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.004499981	0.22499905
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.004428112	0.22140559999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.22140559999999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004428112	0.22140559999999998
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004428112	0.22140559999999998
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004428112	0.22140559999999998
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.004428112	0.22140559999999998
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.22140559999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004428112	0.22140559999999998
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.22140559999999998
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.004428112	0.22140559999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.22140559999999998
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.004428112	0.22140559999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.22140559999999998
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.004428112	0.22140559999999998
REYNOLDS SYNDROME	0.00440529	0.2202645
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.2202645
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00440529	0.2202645
TYROSINEMIA, TYPE I; TYRSN1	0.00440529	0.2202645
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00440529	0.2202645
IMMUNODEFICIENCY 16	0.00440529	0.2202645
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00440529	0.2202645
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00440529	0.2202645
CASPASE 8 DEFICIENCY	0.00440529	0.2202645
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.2202645
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.2202645
HEMOGLOBIN--BETA LOCUS	0.00440529	0.2202645
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00440529	0.2202645
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.2202645
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00440529	0.2202645
FELTY SYNDROME	0.00440529	0.2202645
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.2202645
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.2202645
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2A	0.00440529	0.2202645
APOLIPOPROTEIN C-II DEFICIENCY	0.00440529	0.2202645
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.2202645
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.2202645
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.2202645
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.2202645
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 1	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 2	0.00440529	0.2202645
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.2202645
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.2202645
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00440529	0.2202645
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.2202645
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.2202645
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.2202645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.2202645
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.2202645
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00440529	0.2202645
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.2202645
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.2202645
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00440529	0.2202645
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.2202645
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00440529	0.2202645
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.2202645
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.2202645
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.2202645
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00440529	0.2202645
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.2202645
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.2202645
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00440529	0.2202645
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.00440529	0.2202645
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.2202645
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00440529	0.2202645
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.2202645
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00440529	0.2202645
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.2202645
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.2202645
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.2202645
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 2	0.00440529	0.2202645
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2B	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 1	0.00440529	0.2202645
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.2202645
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004130181	0.20650905
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.004130181	0.20650905
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004130181	0.20650905
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004130181	0.20650905
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2040815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2040815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2040815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2040815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2040815
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.2040815
LYMPHOKINE DEFICIENCY	0.00408163	0.2040815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2040815
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.2040815
PYGMY	0.00408163	0.2040815
NEPHROSIALIDOSIS	0.00408163	0.2040815
DERMATITIS, ATOPIC	0.00408163	0.2040815
SCHIZOPHRENIA 4	0.00408163	0.2040815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2040815
AREDYLD	0.00408163	0.2040815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2040815
MYOPATHY, SPHEROID BODY	0.00408163	0.2040815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2040815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2040815
ZINC, ELEVATED PLASMA	0.00408163	0.2040815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2040815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2040815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2040815
PITUITARY DWARFISM IV	0.00408163	0.2040815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2040815
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.2040815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2040815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2040815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2040815
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.2040815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2040815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2040815
OVARIAN CANCER	0.00408163	0.2040815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2040815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2040815
CARBOXYLESTERASE 1	0.00408163	0.2040815
APOLIPOPROTEIN(A)	0.00408163	0.2040815
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.2040815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2040815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2040815
LARON SYNDROME	0.00408163	0.2040815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2040815
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.2040815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2040815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2040815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2040815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2040815
BEETURIA	0.00408163	0.2040815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2040815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2040815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2040815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2040815
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2040815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2040815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2040815
HYPERPROGLUCAGONEMIA	0.00408163	0.2040815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2040815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2040815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2040815
PACMAN DYSPLASIA	0.00408163	0.2040815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2040815
OSTEOGENIC SARCOMA	0.00408163	0.2040815
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.2040815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2040815
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.2040815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2040815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2040815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2040815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2040815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.2040815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2040815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2040815
PERRY SYNDROME	0.00408163	0.2040815
ALKAPTONURIA	0.00408163	0.2040815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2040815
FINGERPRINT BODY MYOPATHY	0.00408163	0.2040815
DELETED IN AZOOSPERMIA	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2040815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2040815
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00408163	0.2040815
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.2040815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2040815
ICHTHYOSIS, X-LINKED	0.00408163	0.2040815
XANTHINURIA, TYPE I	0.00408163	0.2040815
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.2040815
DERMATOLEUKODYSTROPHY	0.00408163	0.2040815
GLUTATHIONE REDUCTASE	0.00408163	0.2040815
PARAOXONASE 1	0.00408163	0.2040815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2040815
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.2040815
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.2040815
HEINZ BODY ANEMIAS	0.00408163	0.2040815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2040815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2040815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2040815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2040815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2040815
GONADOBLASTOMA	0.00408163	0.2040815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2040815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2040815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2040815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2040815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2040815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2040815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2040815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2040815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2040815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2040815
PENDRED SYNDROME	0.00408163	0.2040815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2040815
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.2040815
SPINAL ARACHNOIDITIS	0.00408163	0.2040815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2040815
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.2040815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2040815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2040815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2040815
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.2040815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2040815
HYPOASCORBEMIA	0.00408163	0.2040815
ONCOCYTOMA	0.00408163	0.2040815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2040815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2040815
PROGESTERONE RESISTANCE	0.00408163	0.2040815
GLUTATHIONURIA	0.00408163	0.2040815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2040815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2040815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2040815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2040815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2040815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2040815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2040815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2040815
XM SYSTEM	0.00408163	0.2040815
CALVARIAL HYPEROSTOSIS	0.00408163	0.2040815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2040815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2040815
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.2040815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2040815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2040815
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2040815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2040815
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.2040815
ACETYLATION, SLOW	0.00408163	0.2040815
HOOFT DISEASE	0.00408163	0.2040815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2040815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2040815
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.2040815
ALAND ISLAND EYE DISEASE	0.00408163	0.2040815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2040815
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0040583120000000006	0.20291560000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0040583120000000006	0.20291560000000003
PEROXISOME BIOGENESIS DISORDER 10B	0.0040583120000000006	0.20291560000000003
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0040583120000000006	0.20291560000000003
AL-RAQAD SYNDROME; ARS	0.0040583120000000006	0.20291560000000003
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0040583120000000006	0.20291560000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004058312	0.20291559999999997
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.004058312	0.20291559999999997
RITSCHER-SCHINZEL SYNDROME 1	0.004058312	0.20291559999999997
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004058312	0.20291559999999997
COFFIN-SIRIS SYNDROME 7; CSS7	0.004058312	0.20291559999999997
NOONAN SYNDROME 6; NS6	0.004058312	0.20291559999999997
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004058312	0.20291559999999997
OROFACIODIGITAL SYNDROME VI	0.004058312	0.20291559999999997
DIAPHANOSPONDYLODYSOSTOSIS	0.004058312	0.20291559999999997
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0039068900000000005	0.19534450000000003
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0039068900000000005	0.19534450000000003
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0039068900000000005	0.19534450000000003
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0039068900000000005	0.19534450000000003
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0039068900000000005	0.19534450000000003
LEGIUS SYNDROME	0.0039068900000000005	0.19534450000000003
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0039068900000000005	0.19534450000000003
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0039068900000000005	0.19534450000000003
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0039068900000000005	0.19534450000000003
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0039068900000000005	0.19534450000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.003860473	0.19302365000000002
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0038604729999999997	0.19302365
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0038604729999999997	0.19302365
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0038604729999999997	0.19302365
CATEL-MANZKE SYNDROME; CATMANS	0.0038604729999999997	0.19302365
MECKEL SYNDROME, TYPE 10; MKS10	0.0037090510000000005	0.18545255000000002
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0037090510000000005	0.18545255000000002
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0037090510000000005	0.18545255000000002
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0037090510000000005	0.18545255000000002
KEARNS-SAYRE SYNDROME; KSS	0.0037090510000000005	0.18545255000000002
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.0037090510000000005	0.18545255000000002
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.0037090510000000005	0.18545255000000002
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.0037090510000000005	0.18545255000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.003637182	0.1818591
Aarskog-Scott syndrome	0.003637182	0.1818591
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.003637182	0.1818591
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.003637182	0.1818591
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.003637182	0.1818591
NOONAN SYNDROME 9; NS9	0.003637182	0.1818591
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.003637182	0.1818591
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003637182	0.1818591
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.003637182	0.1818591
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.003637182	0.1818591
CDAGS SYNDROME	0.003637182	0.1818591
FRIAS SYNDROME	0.003637182	0.1818591
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.003637182	0.1818591
NOONAN SYNDROME 2; NS2	0.003637182	0.1818591
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00358423	0.1792115
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00358423	0.1792115
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00358423	0.1792115
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00358423	0.1792115
MECKEL SYNDROME, TYPE 4; MKS4	0.00358423	0.1792115
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.1792115
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.1792115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00358423	0.1792115
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.1792115
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00358423	0.1792115
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00358423	0.1792115
ANIRIDIA	0.00358423	0.1792115
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00358423	0.1792115
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00321443	0.1607215
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00321443	0.1607215
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00321443	0.1607215
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00321443	0.1607215
COFFIN-SIRIS SYNDROME 10; CSS10	0.00321443	0.1607215
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00321443	0.1607215
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00321443	0.1607215
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00321443	0.1607215
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00321443	0.1607215
#613707 LEOPARD SYNDROME 3; LPRD3	0.003016591	0.15082955
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.003016591	0.15082955
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.003016591	0.15082955
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.003016591	0.15082955
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.003016591	0.15082955
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0029447220000000003	0.1472361
DIAMOND-BLACKFAN ANEMIA 5	0.0029447220000000003	0.1472361
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0029447220000000003	0.1472361
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.0029447220000000003	0.1472361
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0029447220000000003	0.1472361
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0029447220000000003	0.1472361
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0029447220000000003	0.1472361
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.0029447220000000003	0.1472361
NOONAN SYNDROME 3; NS3	0.0029447220000000003	0.1472361
SWEENEY-COX SYNDROME; SWCOS	0.0029447220000000003	0.1472361
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029447220000000003	0.1472361
#614976 CARPENTER SYNDROME 2; CRPT2	0.0029447220000000003	0.1472361
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0029447220000000003	0.1472361
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0029447220000000003	0.1472361
CEREBELLOFACIODENTAL SYNDROME	0.0029447220000000003	0.1472361
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0029447220000000003	0.1472361
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0029447220000000003	0.1472361
RAINE SYNDROME	0.0029447220000000003	0.1472361
CHROMOSOME 15Q14 DELETION SYNDROME	0.0029447220000000003	0.1472361
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029447220000000003	0.1472361
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0029447220000000003	0.1472361
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0029447220000000003	0.1472361
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0029447220000000003	0.1472361
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0029447220000000003	0.1472361
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0028732230000000003	0.14366115000000002
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0028732230000000003	0.14366115000000002
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028732230000000003	0.14366115000000002
INFANTILE LIVER FAILURE SYNDROME 1	0.0028732230000000003	0.14366115000000002
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0028732230000000003	0.14366115000000002
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0028732230000000003	0.14366115000000002
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0028732230000000003	0.14366115000000002
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0028732230000000003	0.14366115000000002
WEAVER SYNDROME	0.0028732230000000003	0.14366115000000002
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0028732230000000003	0.14366115000000002
SHUKLA-VERNON SYNDROME; SHUVER	0.0028732230000000003	0.14366115000000002
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0028732230000000003	0.14366115000000002
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028732230000000003	0.14366115000000002
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028732230000000003	0.14366115000000002
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0028732230000000003	0.14366115000000002
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0028732230000000003	0.14366115000000002
PRADER-WILLI SYNDROME; PWS	0.0028732230000000003	0.14366115000000002
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0028732230000000003	0.14366115000000002
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028732230000000003	0.14366115000000002
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0028732230000000003	0.14366115000000002
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0028732230000000003	0.14366115000000002
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0028732230000000003	0.14366115000000002
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0028732230000000003	0.14366115000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0028732230000000003	0.14366115000000002
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0028732230000000003	0.14366115000000002
SULFOCYSTEINURIA	0.0028732230000000003	0.14366115000000002
GRISCELLI SYNDROME, TYPE 1	0.0028732230000000003	0.14366115000000002
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0028732230000000003	0.14366115000000002
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0028732230000000003	0.14366115000000002
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0028732230000000003	0.14366115000000002
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0028732230000000003	0.14366115000000002
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0028732230000000003	0.14366115000000002
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, X-LINKED 90	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0028732230000000003	0.14366115000000002
TIMOTHY SYNDROME; TS	0.0028732230000000003	0.14366115000000002
SCHINDLER DISEASE, TYPE I	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0028732230000000003	0.14366115000000002
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.0028732230000000003	0.14366115000000002
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0028732230000000003	0.14366115000000002
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0028732230000000003	0.14366115000000002
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0028732230000000003	0.14366115000000002
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0028732230000000003	0.14366115000000002
KETOADIPICACIDURIA	0.0028732230000000003	0.14366115000000002
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0028732230000000003	0.14366115000000002
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0028732230000000003	0.14366115000000002
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0028732230000000003	0.14366115000000002
LUSCAN-LUMISH SYNDROME; LLS	0.0028732230000000003	0.14366115000000002
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0028732230000000003	0.14366115000000002
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0028732230000000003	0.14366115000000002
PELIZAEUS-MERZBACHER DISEASE	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0028732230000000003	0.14366115000000002
ELEJALDE DISEASE	0.0028732230000000003	0.14366115000000002
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0028732230000000003	0.14366115000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0028732230000000003	0.14366115000000002
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0028732230000000003	0.14366115000000002
Glycosylphosphatidylinositol biosynthesis defect 18	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0028732230000000003	0.14366115000000002
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0028732230000000003	0.14366115000000002
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0027933000000000003	0.139665
TUKEL SYNDROME	0.0027933000000000003	0.139665
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0027933000000000003	0.139665
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.139665
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0027933000000000003	0.139665
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0027933000000000003	0.139665
NOONAN SYNDROME 10; NS10	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0027933000000000003	0.139665
ACROCRANIOFACIAL DYSOSTOSIS	0.0027933000000000003	0.139665
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0027933000000000003	0.139665
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.0027933000000000003	0.139665
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.139665
608028 THAI SYMPHALANGISM SYNDROME	0.0027933000000000003	0.139665
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.0027933000000000003	0.139665
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.0027933000000000003	0.139665
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.0027933000000000003	0.139665
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.0027933000000000003	0.139665
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0027933000000000003	0.139665
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.0027933000000000003	0.139665
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.0027933000000000003	0.139665
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.0027933000000000003	0.139665
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0027933000000000003	0.139665
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.0027933000000000003	0.139665
LOEYS-DIETZ SYNDROME 5	0.0027933000000000003	0.139665
MCDONOUGH SYNDROME	0.0027933000000000003	0.139665
PURPURA SIMPLEX	0.0027933000000000003	0.139665
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0027933000000000003	0.139665
CHARGE SYNDROME	0.0027933000000000003	0.139665
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0027933000000000003	0.139665
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.0027933000000000003	0.139665
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.0027933000000000003	0.139665
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0027933000000000003	0.139665
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0027933000000000003	0.139665
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0027933000000000003	0.139665
2p15-16.1 microdeletion syndrome	0.0027933000000000003	0.139665
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.0027933000000000003	0.139665
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.0027933000000000003	0.139665
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0027933000000000003	0.139665
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027933000000000003	0.139665
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0027933000000000003	0.139665
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.0027933000000000003	0.139665
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0027933000000000003	0.139665
DEAFNESS, X-LINKED 7; DFNX7	0.0027933000000000003	0.139665
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0027933000000000003	0.139665
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0027933000000000003	0.139665
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0027933000000000003	0.139665
WERNICKE-KORSAKOFF SYNDROME	0.0027933000000000003	0.139665
AASE-SMITH SYNDROME I	0.0027933000000000003	0.139665
HYPERTELORISM, TEEBI TYPE; TBHS	0.0027933000000000003	0.139665
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.0027933000000000003	0.139665
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0027933000000000003	0.139665
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.0027933000000000003	0.139665
SALIH MYOPATHY; SALMY	0.0027933000000000003	0.139665
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027933000000000003	0.139665
#610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	0.0027933000000000003	0.139665
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.0027933000000000003	0.139665
KOSAKI OVERGROWTH SYNDROME; KOGS	0.0027933000000000003	0.139665
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0027933000000000003	0.139665
HOLOPROSENCEPHALY 4	0.0027933000000000003	0.139665
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.0027933000000000003	0.139665
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0027933000000000003	0.139665
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0027933000000000003	0.139665
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0027933000000000003	0.139665
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0027933000000000003	0.139665
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.0027933000000000003	0.139665
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0027933000000000003	0.139665
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0027933000000000003	0.139665
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0027933000000000003	0.139665
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0027933000000000003	0.139665
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0027933000000000003	0.139665
REFSUM DISEASE	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.0027933000000000003	0.139665
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.0027933000000000003	0.139665
MACHADO-JOSEPH DISEASE; MJD	0.0027933000000000003	0.139665
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.0027933000000000003	0.139665
RHYNS SYNDROME; RHYNS	0.0027933000000000003	0.139665
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0027933000000000003	0.139665
FACIOCARDIOMELIC SYNDROME	0.0027933000000000003	0.139665
CLUSTER HEADACHE, FAMILIAL	0.0027933000000000003	0.139665
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.0027933000000000003	0.139665
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0027933000000000003	0.139665
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.0027933000000000003	0.139665
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0027933000000000003	0.139665
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.0027933000000000003	0.139665
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00210084	0.10504200000000001
#278250 WRINKLY SKIN SYNDROME; WSS	0.00210084	0.10504200000000001
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00210084	0.10504200000000001
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00210084	0.10504200000000001
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00210084	0.10504200000000001
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00210084	0.10504200000000001
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00210084	0.10504200000000001
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00210084	0.10504200000000001
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00210084	0.10504200000000001
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00210084	0.10504200000000001
OTOONYCHOPERONEAL SYNDROME	0.00210084	0.10504200000000001
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00210084	0.10504200000000001
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00210084	0.10504200000000001
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00210084	0.10504200000000001
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00210084	0.10504200000000001
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00210084	0.10504200000000001
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00210084	0.10504200000000001
OROFACIODIGITAL SYNDROME IV; OFD4	0.00210084	0.10504200000000001
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00210084	0.10504200000000001
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00210084	0.10504200000000001
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00210084	0.10504200000000001
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00210084	0.10504200000000001
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00210084	0.10504200000000001
Orofaciodigital syndrome XVII	0.00210084	0.10504200000000001
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00210084	0.10504200000000001
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00210084	0.10504200000000001
NEU-LAXOVA SYNDROME 2; NLS2	0.00210084	0.10504200000000001
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00210084	0.10504200000000001
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00210084	0.10504200000000001
OTOFACIOCERVICAL SYNDROME 2	0.00210084	0.10504200000000001
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00210084	0.10504200000000001
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00210084	0.10504200000000001
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.00210084	0.10504200000000001
BARTSOCAS-PAPAS SYNDROME; BPS	0.00210084	0.10504200000000001
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00210084	0.10504200000000001
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00210084	0.10504200000000001
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00210084	0.10504200000000001
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00210084	0.10504200000000001
HYPOGLOSSIA WITH SITUS INVERSUS	0.00210084	0.10504200000000001
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00210084	0.10504200000000001
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00210084	0.10504200000000001
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00210084	0.10504200000000001
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00210084	0.10504200000000001
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00210084	0.10504200000000001
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00210084	0.10504200000000001
SECKEL SYNDROME 4	0.00210084	0.10504200000000001
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00210084	0.10504200000000001
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00210084	0.10504200000000001
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00210084	0.10504200000000001
FIBROCHONDROGENESIS 1; FBCG1	0.00210084	0.10504200000000001
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00210084	0.10504200000000001
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00210084	0.10504200000000001
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00210084	0.10504200000000001
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00210084	0.10504200000000001
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00210084	0.10504200000000001
DIAMOND-BLACKFAN ANEMIA 10	0.00210084	0.10504200000000001
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00210084	0.10504200000000001
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00210084	0.10504200000000001
ROBERTS SYNDROME; RBS	0.00210084	0.10504200000000001
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00210084	0.10504200000000001
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00210084	0.10504200000000001
NEMALINE MYOPATHY 2; NEM2	0.00210084	0.10504200000000001
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00210084	0.10504200000000001
TETRAAMELIA SYNDROME 2; TETAMS2	0.00210084	0.10504200000000001
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00210084	0.10504200000000001
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00210084	0.10504200000000001
SPONDYLOOCULAR SYNDROME; SOS	0.00210084	0.10504200000000001
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00210084	0.10504200000000001
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00210084	0.10504200000000001
GENITOPALATOCARDIAC SYNDROME	0.00210084	0.10504200000000001
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00210084	0.10504200000000001
TAY-SACHS DISEASE; TSD	0.002029341	0.10146705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002029341	0.10146705
MENTAL RETARDATION, X-LINKED 1	0.002029341	0.10146705
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002029341	0.10146705
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002029341	0.10146705
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002029341	0.10146705
SUDDEN CARDIAC FAILURE, INFANTILE	0.002029341	0.10146705
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002029341	0.10146705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002029341	0.10146705
TENORIO SYNDROME; TNORS	0.002029341	0.10146705
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002029341	0.10146705
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002029341	0.10146705
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002029341	0.10146705
COFFIN-LOWRY SYNDROME; CLS	0.002029341	0.10146705
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002029341	0.10146705
KLEEFSTRA SYNDROME	0.002029341	0.10146705
VISCERAL STEATOSIS, CONGENITAL	0.002029341	0.10146705
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002029341	0.10146705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.002029341	0.10146705
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002029341	0.10146705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.002029341	0.10146705
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002029341	0.10146705
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001957472	0.0978736
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001957472	0.0978736
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001957472	0.0978736
Mental retardation, autosomal dominant 21	0.001957472	0.0978736
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001957472	0.0978736
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001957472	0.0978736
PEROXISOME BIOGENESIS DISORDER 5B	0.001957472	0.0978736
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001957472	0.0978736
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001957472	0.0978736
JOUBERT SYNDROME 24	0.001957472	0.0978736
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001957472	0.0978736
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001957472	0.0978736
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001957472	0.0978736
JOUBERT SYNDROME 32; JBTS32	0.001957472	0.0978736
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001957472	0.0978736
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001957472	0.0978736
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001957472	0.0978736
CHROMOSOME 4q21 DELETION SYNDROME	0.001957472	0.0978736
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001957472	0.0978736
JOUBERT SYNDROME 25	0.001957472	0.0978736
JOUBERT SYNDROME 6	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001957472	0.0978736
MARINESCO-SJOGREN SYNDROME; MSS	0.001957472	0.0978736
JOUBERT SYNDROME 28	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001957472	0.0978736
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001957472	0.0978736
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001957472	0.0978736
WARSAW BREAKAGE SYNDROME; WABS	0.001957472	0.0978736
IMMUNODEFICIENCY 23; IMD23	0.001957472	0.0978736
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001957472	0.0978736
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001957472	0.0978736
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001957472	0.0978736
MENTAL RETARDATION, X-LINKED 99	0.001957472	0.0978736
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001957472	0.0978736
PEROXISOME BIOGENESIS DISORDER 3B	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001957472	0.0978736
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001957472	0.0978736
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001957472	0.0978736
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001957472	0.0978736
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001957472	0.0978736
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001957472	0.0978736
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001957472	0.0978736
JOUBERT SYNDROME 8	0.001957472	0.0978736
JOUBERT SYNDROME 27	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001957472	0.0978736
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001957472	0.0978736
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001957472	0.0978736
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001957472	0.0978736
JOUBERT SYNDROME 15	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001957472	0.0978736
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001957472	0.0978736
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001957472	0.0978736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001957472	0.0978736
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001957472	0.0978736
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.08798165
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001759633	0.08798165
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.08798165
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.08798165
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.08798165
Pierpont syndrome	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.08798165
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.08798165
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.08798165
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.08798165
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.08798165
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.08798165
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.08798165
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.08798165
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.08798165
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.08798165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.08798165
PHACE ASSOCIATION	0.001759633	0.08798165
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.08798165
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.08798165
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.08798165
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.08798165
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.08798165
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.08798165
KBG SYNDROME	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.08798165
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.08798165
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.08798165
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.08798165
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.08798165
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.08798165
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.08798165
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.08798165
HARTNUP DISORDER	0.001759633	0.08798165
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.08798165
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.08798165
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.08798165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.08798165
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.08798165
CHROMOSOME 1p35 DELETION SYNDROME	0.001759633	0.08798165
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.08798165
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.08798165
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.08798165
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.08798165
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.08798165
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.08798165
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.08798165
Cerebral creatine deficiency syndrome 2	0.001759633	0.08798165
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.08798165
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.08798165
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.08798165
LANDAU-KLEFFNER SYNDROME	0.001759633	0.08798165
WAISMAN SYNDROME; WSMN	0.001759633	0.08798165
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.08798165
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.08798165
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.08798165
MACDERMOT-WINTER SYNDROME	0.001759633	0.08798165
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.08798165
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.08798165
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.08798165
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.08798165
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.08798165
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.08798165
PALLISTER-HALL SYNDROME	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.08798165
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00111359	0.0556795
MYOTONIC DYSTROPHY 1	0.00111359	0.0556795
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.0556795
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.0556795
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00111359	0.0556795
OPSISMODYSPLASIA; OPSMD	0.00111359	0.0556795
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.00111359	0.0556795
DESBUQUOIS DYSPLASIA 1	0.00111359	0.0556795
OSTEOGENESIS IMPERFECTA, TYPE X	0.00111359	0.0556795
NEMALINE MYOPATHY 7; NEM7	0.00111359	0.0556795
CEREBELLAR HYPOPLASIA	0.00111359	0.0556795
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00111359	0.0556795
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.0556795
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00111359	0.0556795
NEMALINE MYOPATHY 4	0.00111359	0.0556795
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00111359	0.0556795
JOHANSON-BLIZZARD SYNDROME; JBS	0.00111359	0.0556795
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.0556795
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.0556795
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.0556795
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.0556795
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00111359	0.0556795
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.0556795
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00111359	0.0556795
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00111359	0.0556795
JOUBERT SYNDROME 4	0.00111359	0.0556795
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00111359	0.0556795
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.0556795
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.0556795
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.0556795
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.0556795
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.0556795
MENTAL RETARDATION, X-LINKED 93	0.00111359	0.0556795
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.0556795
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00111359	0.0556795
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.0556795
JOUBERT SYNDROME 5	0.00111359	0.0556795
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.0556795
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00111359	0.0556795
DYSTONIA 11, MYOCLONIC	0.00111359	0.0556795
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00111359	0.0556795
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.0556795
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.0556795
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00111359	0.0556795
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.0556795
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.0556795
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.0556795
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.0556795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00111359	0.0556795
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00111359	0.0556795
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00111359	0.0556795
SOTOS SYNDROME 2	0.00111359	0.0556795
PIERSON SYNDROME	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.0556795
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00111359	0.0556795
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00111359	0.0556795
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.0556795
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 5	0.00111359	0.0556795
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00111359	0.0556795
ADDUCTED THUMBS SYNDROME	0.00111359	0.0556795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00111359	0.0556795
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.0556795
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 13	0.00111359	0.0556795
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00111359	0.0556795
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00111359	0.0556795
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 1	0.00111359	0.0556795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.0556795
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.0556795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.0556795
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.0556795
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00111359	0.0556795
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.0556795
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.0556795
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.0556795
DIAMINOPENTANURIA	0.000915751	0.04578755
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.04578755
CROUZON SYNDROME	0.000915751	0.04578755
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04578755
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.04578755
FLYNN-AIRD SYNDROME	0.000915751	0.04578755
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04578755
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04578755
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04578755
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04578755
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.04578755
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04578755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04578755
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04578755
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.04578755
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04578755
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04578755
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04578755
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.04578755
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04578755
ALZHEIMER DISEASE 3; AD	0.000915751	0.04578755
PAPILLORENAL SYNDROME	0.000915751	0.04578755
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.04578755
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04578755
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04578755
PHENYLKETONURIA	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04578755
DARIER-WHITE DISEASE; DAR	0.000915751	0.04578755
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04578755
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04578755
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.04578755
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04578755
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04578755
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04578755
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04578755
2q33.1 deletion syndrome	0.000915751	0.04578755
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04578755
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04578755
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.04578755
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04578755
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04578755
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04578755
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.04578755
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04578755
CRANIOSYNOSTOSIS 2	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04578755
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04578755
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.04578755
Angelman syndrome (Type 1)	0.000915751	0.04578755
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.04578755
HHHH SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04578755
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04578755
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04578755
KIFAFA SEIZURE DISORDER	0.000915751	0.04578755
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04578755
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04578755
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.04578755
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04578755
HUNTINGTON DISEASE; HD	0.000915751	0.04578755
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.04578755
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.04578755
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04578755
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.04578755
HYPERPROLINEMIA, TYPE II	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04578755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04578755
RAMON SYNDROME	0.000915751	0.04578755
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04578755
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04578755
EPILEPSY, READING	0.000915751	0.04578755
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04578755
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.04578755
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.04578755
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04578755
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.04578755
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04578755
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04578755
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04578755
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04578755
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04578755
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04578755
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04578755
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04578755
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.04578755
FILIPPI SYNDROME; FLPIS	0.000915751	0.04578755
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.04578755
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04578755
KUFOR-RAKEB SYNDROME	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.04578755
STURGE-WEBER SYNDROME	0.000915751	0.04578755
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.04578755
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.04578755
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.04578755
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04578755
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04578755
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.04578755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04578755
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04578755
GURRIERI SYNDROME	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04578755
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04578755
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.04578755
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04578755
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.04578755
Angelman syndrome (Type 2)	0.000915751	0.04578755
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.04578755
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04578755
PERRAULT SYNDROME 3	0.000915751	0.04578755
1p36 microdeletion syndrome	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04578755
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04578755
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04578755
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04578755
AUTISM	0.000915751	0.04578755
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04578755
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04578755
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04578755
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.04578755
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04578755
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04578755
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04578755
HYPERLYSINEMIA, TYPE I	0.000915751	0.04578755
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04578755
ALEXANDER DISEASE	0.000915751	0.04578755
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04578755
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.04578755
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04578755
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.04578755
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04578755
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04578755
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04578755
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.04578755
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04578755
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04578755
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04578755
RETT SYNDROME; RTT	0.000915751	0.04578755
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.04578755
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04578755
Wolf-Hirschhorn Syndrome	0.000915751	0.04578755
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.04578755
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.04578755
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04578755
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04578755
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.04578755
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.04578755
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04578755
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.04578755
PARIETAL FORAMINA	0.000915751	0.04578755
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.04578755
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04578755
HYPER-BETA-ALANINEMIA	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0421941
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0421941
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0421941
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.0421941
Cerebral creatine deficiency syndrome 3	0.000843882	0.0421941
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0421941
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.0421941
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.0421941
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.0421941
WAARDENBURG-SHAH SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0421941
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0421941
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.0421941
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.0421941
STEEL SYNDROME; STLS	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.0421941
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.0421941
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.0421941
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.0421941
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.0421941
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.0421941
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.0421941
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0421941
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0421941
CHOPS SYNDROME; CHOPS	0.000843882	0.0421941
BARATELA-SCOTT SYNDROME	0.000843882	0.0421941
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.0421941
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.0421941
Temtamy preaxial brachydactyly syndrome	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.0421941
Bardet-Biedl syndrome 2	0.000843882	0.0421941
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0421941
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0421941
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.0421941
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0421941
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0421941
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0421941
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.0421941
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.0421941
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.0421941
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0421941
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.0421941
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.0421941
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.0421941
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.0421941
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0421941
LOWRY-MACLEAN SYNDROME	0.000843882	0.0421941
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.0421941
SECKEL SYNDROME 9; SCKL9	0.000843882	0.0421941
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.0421941
PELLAGRA-LIKE SYNDROME	0.000843882	0.0421941
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.0421941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0421941
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.0421941
RAHMAN SYNDROME	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0421941
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.0421941
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0421941
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.0421941
AUSTRALIA ANTIGEN	0.000843882	0.0421941
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0421941
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.0421941
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.0421941
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.0421941
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0421941
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.0421941
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.0421941
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.0421941
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.0421941
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0421941
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.0421941
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.0421941
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.0421941
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.0421941
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0421941
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.0421941
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.0421941
#300555 DENT DISEASE 2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0421941
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.0421941
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0421941
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0421941
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0421941
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0421941
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0421941
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.0421941
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0421941
MEIER-GORLIN SYNDROME 7	0.000843882	0.0421941
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.0421941
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.0421941
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0421941
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.0421941
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0421941
MECKEL SYNDROME 13; MKS13	0.000843882	0.0421941
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.0421941
OROTIC ACIDURIA	0.000843882	0.0421941
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0421941
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.0421941
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000843882	0.0421941
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0421941
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0421941
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0421941
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.0421941
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0421941
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.0421941
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.0421941
CURRARINO SYNDROME	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.0421941
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.0421941
ALAZAMI-YUAN SYNDROME	0.000843882	0.0421941
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.0421941
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.0421941
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.0421941
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.0421941
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.0421941
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0421941
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0421941
CULLER-JONES SYNDROME; CJS	0.000843882	0.0421941
Leukotriene C4 synthase deficiency	0.000843882	0.0421941
Jawad syndrome	0.000843882	0.0421941
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.0421941
NETHERTON SYNDROME; NETH	0.000843882	0.0421941
